Malaise and fatigue

R18_MALAI_FATIG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R53 Hospital discharge: ICD-9 — 7807 Hospital discharge: ICD-8 — 79010 Cause of death: ICD-10 — R53 Cause of death: ICD-9 — 7807 Cause of death: ICD-8 — 79010 2 out of 7 registries used, show all original rules.	28858
4. Check minimum number of events None	28858
5. Include endpoints None	28858
6. Filter based on genotype QC (FinnGen only)	28858

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
Special: FATIGUE
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R50-R69
Name in latin: Aegritudo et lassitudo

NAME	R18_MALAI_FATIG
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R53
HD_ICD_9	7807
HD_ICD_8	79010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R53
COD_ICD_9	7807
COD_ICD_8	79010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malaise and fatigue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28858	16217	12641
Unadjusted period prevalence (%)	5.55	5.53	5.57
Median age at first event (years)	70.00	67.30	73.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21161: Matched controls
187452

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

323.0

8061

36685

N02BE01

ATC

paracetamol; systemic, rectal

2.6

323.0

17898

126462

R50.9

ICD-10 Finland

Fever, unspecified

11.4

323.0

3655

3375

R11

ICD-10 Finland

Nausea and vomiting

5.0

323.0

2477

4802

N02AX02

ATC

tramadol; systemic, rectal

2.1

323.0

8687

47332

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.7

323.0

7033

29255

N02AA05

ATC

oxycodone; systemic

3.6

323.0

3686

10506

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

323.0

3356

13589

N05CF01

ATC

zopiclone; oral

2.3

323.0

7213

34242

C07AB07

ATC

bisoprolol; oral

2.4

323.0

10494

54313

N05BA04

ATC

oxazepam; oral

2.9

323.0

6198

23630

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

323.0

3232

10216

XF400

NOMESCO Finland

ECG with 12 standard connections

3.3

323.0

4467

14104

XF600

NOMESCO Finland

Bloodpressure measurement

3.7

323.0

1603

4110

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

323.0

3195

8987

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

323.0

2256

5986

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.5

323.0

3366

9494

R4110

NOMESCO Finland

Physiotherapy

2.2

323.0

5788

27380

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.1

323.0

2523

7753

N30.0

ICD-10 Finland

Acute cystitis

2.9

323.0

3183

10696

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

323.0

10468

46381

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

323.0

3781

12236

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.6

323.0

4669

10927

N05AH04

ATC

quetiapine; oral

3.9

323.0

4652

12759

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

323.0

4745

22383

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

323.0

4807

21991

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.5

323.0

3608

10465

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

323.0

2134

5597

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

323.0

3285

10227

N05CD07

ATC

temazepam; oral

2.6

323.0

2947

10993

SPAT1254

SPAT

Administration of medicine

2.9

323.0

3563

12371

L28

ICPC

Limited function/disability (L)

3.5

323.0

4191

12270

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

323.0

6489

25233

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

323.0

2489

7391

R42

ICD-10 Finland

Dizziness and giddiness

3.6

323.0

5969

18548

A06AD11

ATC

lactulose; oral

3.4

323.0

3878

11548

SPAT1229

SPAT

Assessment of need for aid

3.5

323.0

1909

5181

M79.6

ICD-10 Finland

Pain in limb

2.1

323.0

7271

37400

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

323.0

4216

18820

N05AH03

ATC

olanzapine; systemic

4.7

323.0

1712

3421

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

323.0

3835

15612

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

323.0

3684

14208

H02AB06

ATC

prednisolone; systemic

1.9

323.0

9470

55062

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.6

323.0

1235

1738

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

323.0

1813

4768

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

323.0

11299

71790

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

323.0

4892

23755

I95.1

ICD-10 Finland

Orthostatic hypotension

7.1

323.0

1024

1326

E86

ICD-10 Finland

Volume depletion

9.1

323.0

847

856

S06.0

ICD-10 Finland

Concussion

3.3

323.0

2483

7315

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.2

323.0

4182

13312

M54.5

ICD-10 Finland

Low back pain

2.0

323.0

6406

33611

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

323.0

2278

7538

N05BA01

ATC

diazepam; systemic, rectal

2.9

323.0

3225

10877

R41.0

ICD-10 Finland

Disorientation, unspecified

6.7

323.0

922

1269

K59.09

ICD-10 Finland

Constipation, unspecified

4.0

323.0

1601

3753

C03CA01

ATC

furosemide; systemic

3.2

323.0

7340

26917

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

323.0

1725

4104

G44.2

ICD-10 Finland

Tension-type headache

2.7

323.0

2640

9349

A01

ICPC

Pain general/multiple sites

3.4

323.0

1783

4965

N03AX16

ATC

pregabalin; oral

2.7

323.0

5247

20126

A28

ICPC

Limited function/disability NOS

4.4

323.0

4445

10671

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.8

323.0

1890

4750

N06AX16

ATC

venlafaxine; oral

3.0

323.0

3178

10555

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

323.0

4371

20441

R33

ICD-10 Finland

Retention of urine

3.1

323.0

2056

6355

B01AA03

ATC

warfarin; systemic

2.3

323.0

4329

19149

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

323.0

6432

32545

A02BC02

ATC

pantoprazole; systemic

2.6

323.0

14133

81974

N03AX12

ATC

gabapentin; oral

2.8

323.0

3345

11804

SPAT1216

SPAT

Assessment of functional ability

2.7

323.0

3530

12827

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

5.7

323.0

1551

2584

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

323.0

2101

5424

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

323.0

1849

5252

N06AX11

ATC

mirtazapine; oral

2.8

323.0

7589

31388

N06AB10

ATC

escitalopram; oral

2.5

323.0

4384

17817

J01MA12

ATC

levofloxacin; systemic

2.3

323.0

3876

16809

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

323.0

2022

5313

N06AB04

ATC

citalopram; systemic

2.7

323.0

5204

20199

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.9

323.0

1170

2219

J01MA02

ATC

ciprofloxacin; systemic

1.9

323.0

7957

44327

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

323.0

3632

12181

J01DB01

ATC

cefalexin; oral

2.1

323.0

16559

119325

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.2

323.0

3248

6358

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

+∞

323.0

353

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

323.0

2552

5337

R53

ICD-10 Finland

Malaise and fatigue

979.1

323.0

20814

11084

UJF32

NOMESCO Finland

Coloscopy

2.2

323.0

5374

25344

N06AX21

ATC

duloxetine; oral

3.5

323.0

2560

7075

N03AG01

ATC

valproic acid; systemic, rectal

5.2

323.0

1684

3053

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.3

323.0

1788

3929

A04

ICPC

Weakness/tiredness general

4.1

323.0

3937

9822

R06.0

ICD-10 Finland

Dyspnoea

3.0

323.0

6265

22894

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

323.0

1947

5280

R55

ICD-10 Finland

Syncope and collapse

26.2

323.0

2881

1120

AA1AD

NOMESCO Finland

CT of head and brain

4.5

323.0

6954

18291

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

323.0

4933

18943

R51.80

ICD-10 Finland

Headache

9.7

323.0

3596

3880

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

323.0

3889

15802

A02BC05

ATC

esomeprazole; systemic

1.9

323.0

8086

45339

SPAT1263

SPAT

Sampling

1.8

323.0

8509

50993

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.4

323.0

3324

7533

R56.8

ICD-10 Finland

Other and unspecified convulsions

202.7

323.0

1270

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

323.0

7069

27740

N05AX08

ATC

risperidone; systemic

4.3

323.0

2285

5077

R60.0

ICD-10 Finland

Localized oedema

4.4

323.0

2346

5178

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.2

323.0

6376

22272

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

323.0

3695

13839

A02BC01

ATC

omeprazole; systemic

2.0

322.8

5610

29072

WX892

NOMESCO Finland

Monitored bed care

3.3

321.3

1832

5266

A46

ICD-10 Finland

Erysipelas

2.5

318.9

2896

11177

N03AX09

ATC

lamotrigine; oral

4.8

317.7

1159

2242

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.2

316.4

1873

5529

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.1

315.6

1918

5771

P20

ICPC

Memory disturbance

2.7

315.1

2542

9174

R03AC02

ATC

salbutamol; inhalant

1.7

313.3

10192

65119

N03AE01

ATC

clonazepam; systemic

3.9

312.1

1429

3440

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.8

310.7

844

1139

SPAT1301

SPAT

No procedures

1.9

309.7

6444

35563

N17

ICPC

Vertigo/dizziness

2.7

309.2

2397

8444

R52.9

ICD-10 Finland

Pain, unspecified

3.4

308.7

1675

4633

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

306.9

4259

20103

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.5

304.9

1191

2470

N06DX01

ATC

memantine; oral

3.9

304.1

1386

3321

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

302.2

1546

4080

SPAT1234

SPAT

Support of social functional capacity

4.2

300.4

1246

2738

N06AB06

ATC

sertraline; oral

2.7

297.4

2369

8469

C07AA05

ATC

propranolol; systemic

2.1

297.2

3902

17953

N05AA02

ATC

levomepromazine; systemic

4.4

295.3

1170

2459

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

292.7

4304

20756

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.1

292.6

1784

5368

C08CA01

ATC

amlodipine; oral

1.8

290.2

6760

38566

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

288.2

4482

22085

N05BA06

ATC

lorazepam; systemic, sublingual

3.9

286.1

1311

3151

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

285.8

3605

16265

C03DA01

ATC

spironolactone; oral

2.6

284.4

2301

8286

UKC02

NOMESCO Finland

Cystoscopy

2.2

284.4

3496

15589

I50.0

ICD-10 Finland

Congestive heart failure

3.2

283.5

1656

4827

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

283.2

1183

2614

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

282.8

1639

4749

R02

ICPC

Shortness of breath/dyspnoea

2.5

282.6

2557

9802

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

278.5

2265

8175

Z51.5

ICD-10 Finland

Palliative care

3.6

276.3

1379

3560

N06AA09

ATC

amitriptyline; systemic

2.7

275.9

2089

7224

G04CA02

ATC

tamsulosin; oral

1.9

275.9

4968

25823

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

275.8

3636

16696

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

275.0

3522

15969

ZX120

NOMESCO Finland

Intravenous

2.8

274.2

2043

6998

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

274.2

5301

28260

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

273.3

1962

6567

R60.9

ICD-10 Finland

Oedema, unspecified

4.9

273.0

970

1819

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.6

271.0

2233

8113

XF404

NOMESCO Finland

Ambulatory ECG

2.8

269.3

2010

6888

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

269.1

2732

11097

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

268.3

1403

3757

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

268.2

2067

7219

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

267.9

5572

30421

R52.2

ICD-10 Finland

Other chronic pain

7.4

266.3

681

840

R07.3

ICD-10 Finland

Other chest pain

2.7

265.6

1988

6820

C01DA14

ATC

isosorbide mononitrate; oral

2.2

263.5

3184

14041

Z71.8

ICD-10 Finland

Other specified counselling

1.9

262.9

4648

23930

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

261.0

4031

19705

N06AB03

ATC

fluoxetine; oral

2.3

260.9

2660

10815

B01AC04

ATC

clopidogrel; oral

2.2

259.6

3136

13817

A29

ICPC

General symptom/complaint other

2.5

259.3

2339

8923

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.7

258.9

1981

6883

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

257.0

2208

8201

JN4BD

NOMESCO Finland

Extensive body CT

2.5

254.6

2221

8316

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

252.8

1612

4981

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

251.7

4550

23558

A02BC03

ATC

lansoprazole; oral

1.8

250.7

5592

31120

C09AA05

ATC

ramipril; oral

1.9

244.9

4783

25413

F05.9

ICD-10 Finland

Delirium, unspecified

7.6

244.7

611

726

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

243.4

4008

20012

F03

ICD-10 Finland

Unspecified dementia

4.2

243.3

1020

2255

TAB00

NOMESCO Finland

Lumbar puncture

4.1

239.9

1010

2242

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

238.4

7794

48519

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

237.9

8395

53369

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

237.4

1701

5663

WX002

NOMESCO Finland

Sedation and analgesia

2.0

236.5

3862

19194

W19

ICD-10 Finland

Unspecified fall

2.6

235.6

1976

7220

B01AB05

ATC

enoxaparin; parenteral

1.8

232.8

5599

31771

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

230.7

1796

6284

N05BA12

ATC

alprazolam; oral

2.5

230.6

2114

8105

E87.6

ICD-10 Finland

Hypokalaemia

5.0

230.1

794

1439

C07AB02

ATC

metoprolol; systemic

1.9

228.4

4133

21298

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.7

228.0

847

1661

J01FF01

ATC

clindamycin; systemic

1.8

227.8

5090

28177

R63.4

ICD-10 Finland

Abnormal weight loss

5.6

226.9

713

1159

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.0

226.9

988

2260

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

226.5

6017

35143

N03AX14

ATC

levetiracetam; systemic

6.8

223.0

601

799

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.1

221.8

1354

4050

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

217.8

1287

3759

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

217.7

1960

7429

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

217.6

2378

9937

N30.9

ICD-10 Finland

Cystitis, unspecified

3.3

217.1

1194

3310

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.0

217.0

942

2147

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

214.8

1539

5111

N05AX12

ATC

aripiprazole; systemic

4.2

213.9

881

1912

WX110

NOMESCO Finland

Local anesthesy

1.6

213.6

12984

93843

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

212.3

1511

4997

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.7

211.1

1570

5334

G30.1

ICD-10 Finland

Alzheimer disease with late onset

3.4

210.4

1131

3080

S01.0

ICD-10 Finland

Open wound of scalp

2.7

209.9

1576

5384

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.0

209.4

904

2049

C10AA01

ATC

simvastatin; oral

1.6

209.1

8037

51707

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

207.8

2085

8349

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

207.3

1030

2635

N06AX12

ATC

bupropion; oral

3.1

207.2

1241

3657

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

206.2

1542

5254

P29

ICPC

Psychological sympt/compl other

3.2

205.6

1220

3570

N03AF01

ATC

carbamazepine; oral, rectal

3.4

205.3

1105

3011

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

205.1

5315

30627

G47.3

ICD-10 Finland

Sleep apnoea

1.9

203.3

3892

20346

SPAT1240

SPAT

Therapeutic discussion

2.3

202.6

2076

8393

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

202.5

2265

9549

J01EA01

ATC

trimethoprim; systemic

1.8

201.8

4594

25417

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.6

201.8

1609

5691

P01

ICPC

Feeling anxious/nervous/tense

2.4

200.8

1986

7886

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

200.4

9379

63161

ZXA00

NOMESCO Finland

Right side

1.7

199.4

5050

28853

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.9

198.4

899

2127

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

198.3

1139

3255

R00.2

ICD-10 Finland

Palpitations

2.7

197.9

1474

5006

L17

ICPC

Foot/toe symptom/complaint

1.8

197.7

4627

25797

R03BB04

ATC

tiotropium bromide; inhalant

2.3

196.6

2104

8681

K59.0

ICD-10 Finland

Constipation

3.0

196.5

1226

3714

AN1

Coronary angiography

2.2

196.1

2276

9751

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

21.1

195.7

304

129

A10AE04

ATC

insulin glargine; parenteral

2.4

195.4

1887

7400

N05AF03

ATC

chlorprothixene; systemic

4.7

194.5

708

1357

U04

ICPC

Incontinence urine

3.5

193.6

987

2576

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

192.8

1851

7233

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.8

192.2

471

543

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

192.1

1547

5497

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

192.0

2247

9655

R13

ICD-10 Finland

Dysphagia

2.9

191.5

1321

4273

N03AF02

ATC

oxcarbazepine; oral

5.0

191.1

656

1180

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

190.9

1224

3774

S97

ICPC

Chronic ulcer skin

3.2

190.7

1107

3187

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.4

190.3

739

1513

N06AX26

ATC

vortioxetine; oral

3.1

190.2

1167

3494

A02BA02

ATC

ranitidine; systemic

1.8

189.7

3723

19571

ZXA05

NOMESCO Finland

Left side

1.7

189.3

4729

26837

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

188.4

920

2318

S18

ICPC

Laceration/cut

1.6

188.2

7601

49124

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

187.5

4490

25148

SPAT1053

SPAT

Memory test

2.0

186.0

2839

13620

K92.1

ICD-10 Finland

Melaena

3.1

186.0

1145

3433

R51

ICD-10 Finland

Headache

3.7

185.7

877

2148

H03AA01

ATC

levothyroxine sodium; systemic

1.8

185.5

4233

23343

P01AB01

ATC

metronidazole; oral, rectal

1.6

185.3

7107

45290

R52.0

ICD-10 Finland

Acute pain

5.7

185.3

576

923

N05AD01

ATC

haloperidol; systemic

4.0

184.4

807

1850

G43.9

ICD-10 Finland

Migraine, unspecified

3.3

183.5

1023

2858

XKD00

NOMESCO Finland

Uroflowmetry

1.9

183.1

3226

16312

M79.1

ICD-10 Finland

Myalgia

2.1

182.1

2322

10349

SPAT1262

SPAT

Handing over of treatment supplies

1.8

182.0

3448

17881

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

181.2

6484

40545

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.3

180.6

595

1021

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

180.6

4978

29009

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

180.5

6061

37270

A41.9

ICD-10 Finland

Sepsis, unspecified

4.0

180.5

777

1754

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

180.2

1330

4484

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

178.2

5103

30039

L03

ICPC

Low back symptom/complaint

1.7

177.3

4262

23835

N05AB03

ATC

perphenazine; systemic, rectal

3.7

177.0

853

2124

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.7

176.8

847

2099

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.4

176.3

449

549

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

176.3

1805

7270

G72.8

ICD-10 Finland

Other specified myopathies

7.5

176.1

444

535

B03BA03

ATC

hydroxocobalamin; parenteral

2.8

175.9

1234

4029

207

Kela drug reimbursment

Chronic arrhythmias

2.0

175.9

2693

12911

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

175.8

7373

47860

SPAT1252

SPAT

Overall medication plan or its review

2.6

175.8

1425

5073

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

175.6

2632

12515

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.2

175.2

1011

2894

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

175.0

1197

3846

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.7

174.5

1316

4490

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

174.2

1282

4312

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

174.1

2235

9975

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

173.7

2625

12517

SPAT1097

SPAT

Recording of ECG

1.9

173.6

2812

13767

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.0

172.6

602

1101

P03

ICPC

Feeling depressed

2.4

172.5

1698

6702

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.6

172.4

640

1251

N06AX03

ATC

mianserin; oral

3.1

172.2

1057

3159

N01

ICPC

Headache

2.3

171.7

1852

7643

D09

ICPC

Nausea

3.4

171.3

924

2516

J01AA02

ATC

doxycycline; systemic

1.5

170.0

14717

112104

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

4.2

170.0

701

1520

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

169.4

2550

12131

N06DA03

ATC

rivastigmine; oral, transdermal

3.8

169.2

774

1843

N06DA02

ATC

donepezil; oral

3.0

169.1

1051

3168

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.7

169.1

1296

4464

K30

ICD-10 Finland

Functional dyspepsia

2.2

168.7

1929

8174

E0000UV

ATC

1.5

168.3

7182

46678

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.5

167.3

864

2274

79199

ICD-8 Finland

Headache

+∞

167.2

168

I95.9

ICD-10 Finland

Hypotension, unspecified

7.6

166.1

413

487

A04AA01

ATC

ondansetron; systemic, rectal

2.7

165.9

1252

4272

R31

ICD-10 Finland

Unspecified haematuria

2.1

165.6

2020

8808

XF402

NOMESCO Finland

ECG with work load test

2.1

165.1

2107

9368

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

164.3

2351

10957

N05CF02

ATC

zolpidem; oral

1.8

163.9

3130

16213

SPAT1167

SPAT

Insertion of urinary catheter

3.8

163.9

751

1791

R35

ICD-10 Finland

Polyuria

2.6

163.6

1299

4565

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

163.5

2315

10738

H02AB09

ATC

hydrocortisone; systemic

5.1

163.2

558

998

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

163.2

1943

8380

B01AF02

ATC

apixaban; oral

2.2

162.7

1776

7361

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.5

162.2

616

1232

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.9

161.6

1085

3441

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.9

161.1

428

557

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

8.2

160.9

381

416

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

160.7

1025

3143

D01

ICPC

Abdominal pain/cramps general

2.1

160.6

1990

8729

N04BC05

ATC

pramipexole; oral

2.5

160.5

1421

5303

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

160.4

4923

29377

J01DA01

ATC

[U] cefalexin; systemic

1.5

160.2

11718

85412

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.6

158.9

782

1979

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

158.5

2551

12425

M79.7

ICD-10 Finland

Fibromyalgia

4.1

158.4

670

1487

K59.1

ICD-10 Finland

Functional diarrhoea

2.9

157.9

1028

3195

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

157.7

1888

8154

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.0

157.6

542

976

J01MA14

ATC

moxifloxacin; systemic

2.3

157.6

1649

6695

M04AA01

ATC

allopurinol; systemic

2.0

156.0

2359

11216

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

156.0

1011

3131

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

155.4

2748

13838

S70.0

ICD-10 Finland

Contusion of hip

3.6

154.9

756

1900

N04AA02

ATC

biperiden; systemic

5.0

154.4

532

960

A11

ICPC

Chest pain NOS

2.4

154.2

1409

5341

R4120

NOMESCO Finland

Occupational therapy

2.6

153.1

1238

4392

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

153.0

3971

22575

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

3.4

152.4

814

2197

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

152.0

2269

10728

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

151.8

848

2367

R51.81

ICD-10 Finland

Facial pain NOS

8.0

150.8

363

407

A10BA02

ATC

metformin; oral

1.6

150.6

5019

30511

N05AN01

ATC

lithium; oral

4.4

150.4

588

1210

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

149.8

721

1791

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

149.6

7076

46738

I20.09

ICD-10 Finland

Unstable angina

2.7

149.6

1142

3917

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

149.5

4333

25382

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

149.5

978

3046

SPAT1260

SPAT

Consultation of another employee

1.8

149.4

3263

17601

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.9

149.2

446

680

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

148.7

825

2291

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

148.3

7282

48471

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

148.0

2996

15771

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

147.5

2562

12802

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

147.4

1310

4893

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.5

147.1

560

1122

T90

ICPC

Diabetes non-insulin dependent

1.7

146.8

4070

23535

M25.5

ICD-10 Finland

Pain in joint

1.6

146.1

4785

28921

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.0

145.2

497

890

P76

ICPC

Depressive disorder

2.6

145.1

1149

4023

J01FA06

ATC

roxithromycin; oral

1.5

144.5

7145

47558

M48.0

ICD-10 Finland

Spinal stenosis

2.0

144.5

2110

9879

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.0

144.4

915

2789

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.0

144.0

621

1402

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.8

143.8

514

965

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.1

143.6

373

470

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.1

143.5

419

620

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

142.9

2879

15113

K92.0

ICD-10 Finland

Haematemesis

4.2

142.9

586

1263

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

141.8

4168

24456

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.7

141.5

512

974

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

141.2

703

1795

N19

ICD-10 Finland

Unspecified kidney failure

3.5

140.4

706

1817

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.8

140.0

500

938

J01CA04

ATC

amoxicillin; systemic

1.5

139.8

15339

119721

G20

ICD-10 Finland

Parkinson disease

3.4

138.9

743

2006

H02AB07

ATC

prednisone; oral

1.8

138.8

2569

13100

Z00.0

ICD-10 Finland

General medical examination

1.7

138.8

3332

18453

SPAT1255

SPAT

Intravenous administration of medicine

2.5

138.6

1221

4534

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

138.2

865

2614

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

138.0

1172

4265

N05BE01

ATC

buspirone; oral

3.7

137.4

647

1577

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.0

137.2

595

1350

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.1

137.0

804

2322

S22.3

ICD-10 Finland

Fracture of rib

2.5

136.8

1204

4467

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.1

136.5

465

828

WW500

NOMESCO Finland

Blood transfusion

3.2

135.9

769

2165

C10AA05

ATC

atorvastatin; oral

1.5

135.9

6616

43735

205

Kela drug reimbursment

Chronic hypertension

1.6

135.7

5038

31306

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

135.7

1689

7399

R05

ICD-10 Finland

Cough

1.7

135.4

3369

18836

D11

ICPC

Diarrhoea

2.0

135.4

1928

8923

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

135.1

1450

5940

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

65.8

134.0

162

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

133.8

1367

5471

K90

ICPC

Stroke/cerebrovascular accident

3.9

133.6

596

1387

SPAT1101

SPAT

Orthostatic test

3.0

133.0

855

2630

R25.1

ICD-10 Finland

Tremor, unspecified

3.7

132.5

633

1562

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.1

132.0

446

787

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

131.3

3022

16497

I50

ICD-10 Finland

Heart failure

3.7

131.2

613

1484

N06AA12

ATC

doxepin; systemic

2.6

131.0

1043

3661

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

130.9

998

3416

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.3

130.4

520

1091

P99

ICPC

Psychological disorders other

3.9

130.1

580

1349

P06

ICPC

Sleep disturbance

2.0

129.9

1744

7876

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

129.7

2003

9558

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.4

129.5

681

1814

ZXA10

NOMESCO Finland

Bilateral

1.7

129.4

3281

18422

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.4

129.3

499

1014

SPAT1104

SPAT

Monitoring of emergency patient

2.3

129.0

1265

4961

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.1

128.9

542

1195

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

128.9

1049

3725

A03

ICPC

Fever

1.8

128.9

2672

14117

D12

ICPC

Constipation

3.3

128.7

694

1885

X58

ICD-10 Finland

Exposure to other specified factors

1.8

128.1

2325

11753

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.1

128.0

780

2314

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.0

127.9

375

558

JN4AD

NOMESCO Finland

Body CT examination

2.3

127.7

1321

5317

U05

ICPC

Urination problems other

2.8

127.6

918

3032

R52.1

ICD-10 Finland

Chronic intractable pain

34.3

127.2

173

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

126.7

673

1807

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

126.6

1167

4431

EBA00

NOMESCO Finland

Extraction of tooth

1.5

126.4

5772

37493

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.5

126.3

1089

3991

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

126.2

3579

20715

I49.5

ICD-10 Finland

Sick sinus syndrome

3.3

125.6

701

1953

A08

ICPC

Swelling

3.1

125.3

765

2272

J01CA08

ATC

pivmecillinam; oral

1.5

125.3

6346

42120

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

125.2

655

1738

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

125.0

1075

3935

L01

ICPC

Neck symptom/complaint

1.8

125.0

2325

11845

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

124.7

1668

7517

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.6

124.4

459

891

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.0

124.2

790

2411

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

123.7

1320

5386

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

123.1

2677

14337

F34.1

ICD-10 Finland

Dysthymia

3.2

123.0

699

1973

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.4

122.8

650

1740

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

122.7

1476

6361

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.3

122.5

400

679

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.3

122.4

486

1015

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

122.3

1450

6206

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

122.3

1654

7487

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

122.1

1722

7922

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.2

121.8

708

2031

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

121.8

3322

19001

P15

ICPC

Chronic alcohol abuse

3.8

121.6

551

1299

N05AH02

ATC

clozapine; systemic

4.8

121.4

434

815

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

121.4

122

SPAT1172

SPAT

Guidance concerning hydration

4.5

121.3

462

926

F10.24

ICD-10 Finland

Alcohol depence active use

6.1

121.3

351

514

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.3

121.2

658

1796

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

120.8

1096

4126

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.1

120.8

350

513

U02

ICPC

Urinary frequency/urgency

1.8

120.8

2239

11383

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

120.1

687

1947

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

120.0

730

2162

K07

ICPC

Swollen ankles/oedema

2.9

119.8

771

2372

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.8

119.4

426

798

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

118.8

6590

44446

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.9

118.7

414

757

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

118.6

547

1310

N03AX11

ATC

topiramate; oral

4.4

118.2

462

950

G04BD12

ATC

mirabegron; oral

2.0

117.9

1751

8216

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

117.8

890

3027

K08.3

ICD-10 Finland

Retained dental root

2.2

117.1

1250

5098

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

116.6

853

2845

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

116.6

3988

24155

G30.8

ICD-10 Finland

Other Alzheimer disease

4.6

115.8

427

828

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

115.5

900

3113

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

115.5

687

2003

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.3

115.4

462

973

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

115.4

882

3019

N06AB05

ATC

paroxetine; oral

2.3

115.3

1123

4379

F61.0

ICD-10 Finland

Mixed personality disorders

5.1

114.6

384

672

S72.0

ICD-10 Finland

Fracture of neck of femur

3.0

114.4

717

2165

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

114.3

1090

4209

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

114.2

1910

9358

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

114.1

3513

20705

N07BB01

ATC

disulfiram; oral

2.8

114.0

796

2580

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.4

114.0

438

886

SPAT1251

SPAT

Organisation of medication

3.0

114.0

726

2217

E87.5

ICD-10 Finland

Hyperkalaemia

5.2

113.0

375

649

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.1

112.8

471

1032

P74

ICPC

Anxiety disorder/anxiety state

3.0

111.7

698

2105

SPAT1139

SPAT

Nutrition survey

3.1

111.4

667

1952

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.9

111.3

737

2309

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

111.3

1462

6528

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.8

110.5

785

2569

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

110.5

1298

5527

R06AE07

ATC

cetirizine; oral

1.4

110.0

7448

51980

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.6

109.5

408

800

A99

ICPC

Disease/condition unspecnature/site

2.1

109.3

1402

6198

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.8

109.2

328

504

R4190

NOMESCO Finland

Nutritional therapy

3.1

108.9

652

1907

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

108.8

4779

30582

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

108.1

1361

5968

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

108.1

923

3362

WVA20

NOMESCO Finland

Medicine administration

3.9

108.0

480

1113

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.0

108.0

461

1031

A10BH01

ATC

sitagliptin; oral

1.9

107.4

1676

7998

U07

ICPC

Urine symptom/complaint other

2.3

107.4

1041

4048

D07AC01

ATC

betamethasone; topical

1.4

107.1

5882

39393

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

107.0

550

1439

G93.3

ICD-10 Finland

Postviral fatigue syndrome

17.5

106.7

176

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

106.4

1792

8794

S29

ICPC

Skin symptom/complaint other

1.6

105.7

2860

16260

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.2

105.5

1182

4924

R06.4

ICD-10 Finland

Hyperventilation

4.8

105.3

372

690

RS221

NOMESCO Finland

5.0

104.5

358

642

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.3

104.2

570

1564

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

104.0

1577

7444

C09AA02

ATC

enalapril; systemic

1.6

103.9

3453

20693

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.3

103.6

407

842

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

103.5

1770

8727

R05

ICPC

Cough

1.5

103.0

3761

23043

R03DC03

ATC

montelukast; oral

1.7

102.4

2601

14519

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

102.4

943

3574

N06AX05

ATC

trazodone; oral

3.6

102.3

504

1275

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

102.1

643

1949

R06.5

ICD-10 Finland

Mouth breathing

2.0

102.1

1494

6955

A07AA02

ATC

nystatin; oral

2.3

101.8

1051

4213

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.6

101.7

497

1249

K78

ICPC

Atrial fibrillation/flutter

2.1

101.6

1306

5774

N05AA01

ATC

chlorpromazine; systemic, rectal

5.0

101.3

348

626

A10BH05

ATC

linagliptin; oral

2.5

101.1

856

3101

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

101.0

8204

58857

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

100.5

907

3399

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.2

100.5

289

420

A10BB12

ATC

glimepiride; oral

2.0

100.3

1329

5948

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

100.2

1523

7189

SPAT1279

SPAT

Preparation of immediate hospitalisation

7.3

100.1

255

313

A03FA02

ATC

cisapride; oral, rectal

2.0

100.0

1367

6195

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.9

99.8

436

996

N05BA02

ATC

chlordiazepoxide; systemic

3.5

99.8

506

1310

WX882

NOMESCO Finland

High dependency care

3.3

99.7

550

1518

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.2

99.7

409

882

K02.1

ICD-10 Finland

Caries of dentine

1.4

99.6

9837

72869

N18.8

ICD-10 Finland

Other chronic renal failure

3.3

99.4

534

1445

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

99.2

544

1495

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

99.2

2233

12025

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.0

99.2

422

941

P70

ICPC

Dementia

4.4

98.2

378

766

N18

ICPC

Paralysis/weakness

4.1

98.2

406

882

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

98.1

1702

8427

C01AA05

ATC

digoxin; systemic

2.0

97.9

1454

6803

A07AA09

ATC

vancomycin; oral

5.9

97.3

291

445

A01AB09

ATC

miconazole; local oral

1.9

97.3

1492

7065

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.4

96.5

307

506

E000001

ATC

1.5

96.5

3493

21315

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

5.6

96.4

298

475

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

96.1

3312

19975

R41.3

ICD-10 Finland

Other amnesia

3.2

95.9

546

1542

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

95.7

12455

96180

TK800

NOMESCO Finland

Hemodialysis

3.9

95.6

428

999

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

95.6

2084

11108

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

95.5

1062

4405

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

95.5

699

2328

R32

ICD-10 Finland

Unspecified urinary incontinence

3.3

95.4

519

1418

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

95.4

349

672

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

95.2

1153

4966

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

95.1

1350

6206

N29

ICPC

Neurological sympt/complt other

4.0

95.1

407

913

WYA20

NOMESCO Finland

Home visit

5.2

95.0

315

545

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

94.7

4034

25522

M05BX04

ATC

denosumab; parenteral

2.5

94.7

779

2778

B34.9

ICD-10 Finland

Viral infection, unspecified

3.4

94.6

495

1313

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.5

94.5

474

1216

Z00.8

ICD-10 Finland

Other general examinations

2.0

94.2

1238

5517

C08CA13

ATC

lercanidipine; oral

1.7

94.2

2078

11113

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

94.1

677

2234

SPAT1211

SPAT

Application of soft bandage

1.9

94.0

1566

7638

A10AE05

ATC

insulin detemir; parenteral

2.3

93.8

986

3983

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

93.6

3276

19815

Y94.0

ICD-10 Finland

Accident at home

4.1

93.6

390

853

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

93.5

1178

5157

F32

ICD-10 Finland

Depressive episode

2.3

93.4

902

3497

B03XA02

ATC

darbepoetin alfa; parenteral

4.3

93.3

373

785

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

93.2

1072

4515

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.2

93.1

383

828

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

4.6

93.0

344

670

F21

ICPC

9.3

92.9

203

194

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

92.6

664

2186

M05BA04

ATC

alendronic acid; oral

2.1

92.5

1193

5274

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.7

92.4

250

335

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.0

92.4

398

898

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.7

91.9

331

627

N06AG02

ATC

moclobemide; oral

2.4

91.9

822

3065

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

91.8

501

1372

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

91.6

4519

29445

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.1

91.5

308

542

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

91.5

584

1786

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

91.4

773

2797

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.6

91.3

445

1116

H02AA02

ATC

fludrocortisone; oral

7.3

91.3

231

281

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.6

91.2

440

1094

S00.0

ICD-10 Finland

Superficial injury of scalp

3.8

91.1

414

979

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.6

90.9

283

455

A41.8

ICD-10 Finland

Other specified sepsis

4.7

90.8

332

639

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.5

90.8

287

470

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.2

90.7

260

377

R04.0

ICD-10 Finland

Epistaxis

2.0

90.6

1222

5502

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.1

90.6

262

384

F01.9

ICD-10 Finland

Vascular dementia, unspecified

4.9

90.3

313

569

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

90.3

9409

69854

SPAT1310

SPAT

Counselling related to known health issue

1.4

90.1

5520

37477

J02AC01

ATC

fluconazole; systemic

1.4

89.9

6457

45094

B01AB10

ATC

tinzaparin; parenteral

2.1

89.8

1158

5119

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.5

89.8

734

2606

L29

ICPC

Musculoskeletal sympt/complt other

2.0

89.7

1250

5699

I20.00

ICD-10 Finland

Unstable angina

2.9

89.6

599

1886

L02

ICPC

Back symptom/complaint

1.9

89.5

1459

7057

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

89.4

1273

5855

M10.9

ICD-10 Finland

Gout, unspecified

2.1

89.4

1082

4657

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.9

89.4

579

1786

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

89.2

1519

7459

WX872

NOMESCO Finland

Intensive care

2.3

89.0

878

3439

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

88.9

1057

4513

R03BA05

ATC

fluticasone; inhalant

1.6

88.8

3012

18062

L12

ICPC

Hand/finger symptom/complaint

1.7

88.8

2291

12807

Z50.1

ICD-10 Finland

Other physical therapy

2.2

88.7

944

3836

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.5

88.7

338

679

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

88.6

7243

51665

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.5

88.5

333

660

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.9

88.4

596

1886

A11CC03

ATC

alfacalcidol; systemic

3.5

88.3

449

1165

R03BA02

ATC

budesonide; inhalant

1.6

88.3

2907

17307

D06

ICPC

Abdominal pain localized other

1.9

87.5

1332

6282

M54.2

ICD-10 Finland

Cervicalgia

2.1

87.4

1118

4924

M03BX02

ATC

tizanidine; oral

1.3

87.4

10451

79098

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

87.2

2096

11480

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

87.2

2558

14793

B81

ICPC

Anaemia vit B12/folate deficiency

2.6

87.1

688

2395

Z29

ICPC

Social problem NOS

3.8

87.0

392

920

SPAT1360

SPAT

Extensive global examination

2.0

86.7

1288

6019

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

86.2

680

2367

SPAT1050

SPAT

Extensive neurological examination

3.5

86.2

426

1081

P72

ICPC

Schizophrenia

4.0

86.1

370

833

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

86.0

981

4112

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

85.8

1260

5860

H02AB04

ATC

methylprednisolone; systemic

1.6

85.6

2348

13336

C09CA06

ATC

candesartan; oral

1.5

85.5

3374

20931

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.6

85.4

319

628

RS222

NOMESCO Finland

5.1

85.2

288

510

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.0

85.1

362

808

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

4.4

84.8

325

657

N87

ICPC

Parkinsonism

4.4

84.6

324

654

M03BX01

ATC

baclofen; systemic

4.3

84.6

332

687

XG466

NOMESCO Finland

Sleep oxymetry

2.7

84.5

614

2035

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

84.5

3048

18525

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

84.2

803

3093

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

84.2

631

2132

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

83.9

6460

45515

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

83.8

899

3663

UJD02

NOMESCO Finland

Gastroscopy

2.3

83.6

837

3301

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

83.5

578

1861

G04BD08

ATC

solifenacin; oral

2.0

83.2

1119

5028

H53.2

ICD-10 Finland

Diplopia

2.9

83.2

539

1664

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.0

82.9

244

366

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.2

82.7

235

337

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

82.7

1997

10944

R01AD09

ATC

mometasone; nasal

1.3

82.6

7442

53743

C09CA01

ATC

losartan; oral

1.5

82.6

3846

24694

Angiography of the heart and coronary arteries

2.0

82.4

1140

5180

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.6

82.3

304

592

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.1

82.2

481

1384

J46

ICD-10 Finland

Status asthmaticus

3.1

82.1

476

1362

R12

ICD-10 Finland

Heartburn

2.0

82.0

1163

5336

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

81.9

1028

4490

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

81.7

685

2467

G04BD07

ATC

tolterodine; oral

2.3

81.4

848

3408

A02BA04

ATC

nizatidine; systemic

1.9

81.4

1337

6477

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

8.4

81.2

188

199

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

81.0

909

3782

A05

ICPC

Feeling ill

2.1

80.8

1002

4354

C03AA03

ATC

hydrochlorothiazide; oral

1.8

80.6

1558

7975

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

80.3

1570

8067

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

80.1

841

3391

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

80.0

2842

17186

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

80.0

1631

8490

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

79.9

428

1156

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

79.9

623

2154

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.9

79.8

354

820

M54

ICD-10 Finland

Dorsalgia

1.7

79.8

1736

9221

N06AX22

ATC

agomelatine; oral

3.6

79.6

384

956

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

79.3

1036

4600

L14

ICPC

Leg/thigh symptom/complaint

1.9

79.3

1178

5499

E66.8

ICD-10 Finland

Other obesity

2.3

79.2

817

3266

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

15.3

79.2

137

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

79.1

1382

6838

N06AA06

ATC

trimipramine; systemic

3.0

78.9

479

1416

183

Kela drug reimbursment

Lamotrigin and topiramate

8.1

78.9

187

206

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.4

78.8

171

162

Z08

ICPC

Social welfare problem

4.9

78.8

274

501

N05AC02

ATC

thioridazine; oral

3.3

78.3

419

1131

K04

ICPC

Palpitations/awareness of heart

2.2

78.3

853

3499

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

78.3

854

3508

J45

ICD-10 Finland

Asthma

1.8

77.7

1531

7882

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.4

77.7

402

1058

C02AC05

ATC

moxonidine; oral

2.3

77.6

752

2919

N28

ICPC

Limited function/disability (N)

4.2

77.6

317

682

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

77.5

732

2805

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.5

77.5

394

1023

D07AA02

ATC

hydrocortisone; topical

1.6

77.4

2266

13064

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

77.2

1879

10307

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

77.1

1191

5640

R03AC03

ATC

terbutaline; inhalant

1.6

76.8

2250

12974

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

76.7

578

1957

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

76.5

877

3680

R5110

SPAT

3.0

76.2

466

1384

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.5

75.8

376

957

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.5

75.7

372

940

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.6

75.5

234

375

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.6

75.5

609

2146

H57.1

ICD-10 Finland

Ocular pain

2.8

75.5

521

1675

A06AC51

ATC

ispaghula, combinations; systemic

2.2

75.3

806

3280

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

75.3

627

2247

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

75.2

1254

6102

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.6

75.1

277

539

R10.0

ICD-10 Finland

Acute abdomen

2.7

75.0

543

1798

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

74.9

1623

8605

R1250

NOMESCO Finland

Evaluation of functional capability

3.3

74.8

410

1127

K29

ICPC

Cardiovascular sympt/complt other

2.4

74.6

698

2663

WX722

NOMESCO Finland

PEEP

2.2

74.3

813

3341

R04.2

ICD-10 Finland

Haemoptysis

2.6

74.3

596

2095

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.7

74.2

537

1777

G40

ICD-10 Finland

Epilepsy

7.5

74.1

184

218

R25.2

ICD-10 Finland

Cramp and spasm

3.3

74.1

407

1121

SPAT1304

SPAT

Counselling and guidance related to ageing

2.0

74.0

1058

4865

R54

ICD-10 Finland

Senility

77.4

73.9

C08CA02

ATC

felodipine; oral

1.8

73.8

1518

7916

A12BA01

ATC

potassium chloride; oral

2.3

73.7

761

3045

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

73.6

654

2428

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.8

73.6

263

495

L04

ICPC

Chest symptom/complaint

2.1

73.5

919

4004

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.6

73.4

351

868

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.1

73.3

432

1251

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

73.2

4615

31266

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.1

73.1

210

306

G43.3

ICD-10 Finland

Complicated migraine

4.7

73.0

262

496

M01AH02

ATC

rofecoxib; oral

1.6

72.8

2064

11789

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

72.6

1340

6749

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

72.3

444

1323

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

72.2

919

4034

S80.0

ICD-10 Finland

Contusion of knee

2.0

72.1

1000

4544

L04AA06

ATC

mycophenolic acid; systemic

4.1

71.9

298

650

H02AB02

ATC

dexamethasone; systemic

1.7

71.8

1562

8282

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

71.8

1028

4728

WZC30

NOMESCO Finland

Teaching

1.6

71.7

2051

11741

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

71.6

604

2180

R07.2

ICD-10 Finland

Precordial pain

3.3

71.6

387

1053

-1

NOMESCO Finland

1.4

71.6

5500

38503

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.1

71.5

431

1268

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

71.3

1333

6741

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

71.2

1086

5117

M02AA07

ATC

piroxicam; topical

1.3

71.1

5940

42131

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.2

71.0

393

1089

M01AX17

ATC

nimesulide; oral

1.4

70.5

3909

25851

J01MA06

ATC

norfloxacin; oral

1.6

70.5

2085

12033

SPAT1125

SPAT

Stoma care and guidance

4.0

70.5

297

658

R96

ICPC

Asthma

1.8

70.3

1362

6968

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

2.9

70.2

458

1420

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

70.2

5599

39401

R29

ICPC

Respiratory symptom/complaint other

2.0

70.2

1003

4609

R30.0

ICD-10 Finland

Dysuria

2.5

70.1

600

2183

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

69.9

760

3114

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

69.8

424

1253

N05AF05

ATC

zuclopenthixol; systemic

4.8

69.7

244

450

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.0

69.6

424

1257

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

69.4

552

1931

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.0

69.3

435

1316

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

69.3

1481

7813

SPAT1127

SPAT

Enema

6.6

69.2

187

251

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.4

69.2

266

540

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.5

69.1

189

258

F32.8

ICD-10 Finland

Other depressive episodes

4.0

69.1

294

657

A27

ICPC

Fear of other disease NOS

2.2

69.1

730

2952

M01AE02

ATC

naproxen; oral, rectal

1.3

69.1

9715

74188

R05FB02

ATC

cough suppressants and expectorants

1.3

69.0

6326

45461

U01

ICPC

Dysuria/painful urination

1.9

68.7

1154

5626

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

68.7

722

2913

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

68.6

1754

9737

K80

ICPC

Cardiac arrhythmia NOS

1.9

68.5

1163

5691

P28

ICPC

Limited function/disability (P)

6.0

68.4

199

295

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.4

68.4

637

2423

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

68.2

853

3716

SPAT1312

SPAT

General health counselling

1.3

68.1

5439

38244

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.1

67.9

279

604

L16

ICPC

Ankle symptom/complaint

1.7

67.6

1567

8463

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

67.6

242

457

R40.0

ICD-10 Finland

Somnolence

13.1

67.5

124

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

67.3

2294

13699

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

67.3

1680

9267

S20.2

ICD-10 Finland

Contusion of thorax

2.2

67.2

766

3207

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.6

67.0

244

469

K85

ICPC

Elevated blood pressure

1.5

66.9

2292

13701

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

3.3

66.8

363

992

R40.2

ICD-10 Finland

Coma, unspecified

6.4

66.7

186

261

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

66.4

381

1084

3AC01

NOMESCO Finland

4.9

66.3

229

416

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

66.3

1755

9833

X57

ICD-10 Finland

Unspecified privation

3.0

66.1

408

1220

D02

ICPC

Abdominal pain epigastric

2.0

66.0

891

4003

A97

ICPC

No disease

1.5

66.0

2477

15115

WZA90

NOMESCO Finland

Other doctors statement

1.4

65.9

3680

24327

H26.4

ICD-10 Finland

After-cataract

1.8

65.8

1310

6755

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.0

65.7

283

640

M54.8

ICD-10 Finland

Other dorsalgia

2.3

65.6

621

2382

F05.8

ICD-10 Finland

Other delirium

7.0

65.5

171

219

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

65.5

674

2692

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

65.5

679

2722

G04CA01

ATC

alfuzosin; oral

1.6

65.5

1948

11251

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.6

65.4

242

473

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

65.4

443

1407

D64.8

ICD-10 Finland

Other specified anaemias

3.8

65.4

297

704

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.6

65.3

238

458

Z03

ICPC

Housing/neighbourhood problem

6.9

65.3

171

220

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

65.2

1098

5355

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.8

65.2

290

675

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

65.1

455

1474

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

65.0

1363

7142

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

64.7

1107

5429

A02BC04

ATC

rabeprazole; oral

1.8

64.7

1275

6552

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.0

64.7

276

619

SPAT1138

SPAT

Guidance concerning bowel function

3.8

64.4

292

691

RS220

NOMESCO Finland

4.2

64.4

259

550

N30

ICD-10 Finland

Cystitis

1.8

64.4

1104

5419

N05CD02

ATC

nitrazepam; oral

3.3

64.2

348

950

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

64.1

554

2027

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

64.1

1132

5612

I50.1

ICD-10 Finland

Left ventricular failure

2.1

64.0

789

3417

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

64.0

483

1640

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

63.7

522

1854

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

63.7

1176

5917

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

63.7

913

4199

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

63.7

969

4556

F45.0

ICD-10 Finland

Somatization disorder

10.3

63.6

131

113

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.8

63.2

283

663

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.3

63.2

338

914

R07.0

ICD-10 Finland

Pain in throat

1.9

63.1

939

4381

C10AC01

ATC

colestyramine; oral

2.8

62.9

438

1416

R03BA01

ATC

beclometasone; inhalant

1.5

62.8

2201

13211

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

62.6

254

544

N17.8

ICD-10 Finland

Other acute renal failure

4.6

62.6

229

443

J20

ICD-10 Finland

Acute bronchitis

1.7

62.5

1438

7744

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

62.5

332

893

C07AG02

ATC

carvedilol; oral

1.9

62.5

973

4614

J01CF05

ATC

flucloxacillin; systemic

2.3

62.3

605

2349

N06AA10

ATC

nortriptyline; systemic

3.3

62.3

341

938

R4130

NOMESCO Finland

Speech therapy

2.9

62.1

393

1196

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

62.0

8878

67575

M54.3

ICD-10 Finland

Sciatica

2.0

61.7

891

4106

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

61.7

542

2001

N99

ICPC

Neurological disease other

4.4

61.6

235

474

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

61.6

1556

8599

U08

ICPC

Urinary retention

3.2

61.5

343

956

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.6

61.5

474

1626

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

61.5

827

3710

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.1

61.5

361

1044

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.6

61.4

151

177

P18

ICPC

Medication abuse

8.3

61.4

143

154

C08DB01

ATC

diltiazem; oral

2.0

61.3

886

4086

R18

ICD-10 Finland

Ascites

3.3

61.3

327

882

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.9

61.3

389

1186

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.6

61.3

494

1740

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.5

61.3

125

106

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

61.3

2934

18809

127

Kela drug reimbursment

Transplant complication

4.2

61.2

246

522

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

61.2

927

4351

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

61.2

329

893

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

61.2

359

1038

R60.1

ICD-10 Finland

Generalized oedema

10.0

61.2

128

114

D10

ICPC

Vomiting

2.0

61.0

844

3828

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.7

61.0

284

688

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.0

61.0

259

579

S21

ICPC

Skin texture symptom/complaint

1.6

60.9

1952

11468

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

60.9

856

3907

SPAT1281

SPAT

Other administrative function

1.7

60.9

1292

6793

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

60.8

360

1046

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.1

60.7

349

995

R06.2

ICD-10 Finland

Wheezing

2.2

60.7

685

2854

79010

ICD-8 Finland

Nervousness and debility, Asthenia

+∞

60.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

60.6

297

750

F41.00

ICD-10 Finland

Moderate panic disorder

3.7

60.6

281

678

U13

ICPC

Bladder symptom/complaint other

2.5

60.6

503

1802

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

60.5

533

1971

RD210

NOMESCO Finland

3.2

60.3

332

917

U28

ICPC

Limited function/disability (U)

4.7

60.3

215

405

L05

ICPC

Flank/axilla symptom/complaint

2.0

60.3

824

3721

KMAK

NOMESCO Finland

1.3

60.3

8603

65371

Z72.1

ICD-10 Finland

Alcohol use

4.1

60.2

248

539

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.5

60.2

298

759

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

60.1

914

4298

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.5

60.0

517

1887

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

59.8

822

3719

U71

ICPC

Cystitis/urinary infection other

1.9

59.7

909

4273

N03AX18

ATC

lacosamide; systemic

8.9

59.6

133

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.6

59.6

283

697

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.2

59.5

338

954

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

59.5

1493

8235

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

59.4

783

3486

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

7.3

59.2

149

181

WW200

NOMESCO Finland

Immunization

2.6

59.2

453

1549

C08CA05

ATC

nifedipine; systemic

1.8

59.1

1057

5258

N88

ICPC

Epilepsy

9.9

59.1

124

111

NF3AA

NOMESCO Finland

Femur X-ray examination

3.3

59.1

317

859

K77

ICPC

Heart failure

3.3

58.8

310

829

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

58.8

686

2900

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

58.7

834

3820

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

7.6

58.6

144

169

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.9

58.6

204

375

N06BA04

ATC

methylphenidate; oral

3.1

58.5

348

1016

G50.1

ICD-10 Finland

Atypical facial pain

3.7

58.4

274

668

C08DA01

ATC

verapamil; systemic

2.2

58.3

652

2705

R81

ICPC

Pneumonia

2.4

58.2

533

2011

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

58.1

497

1809

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

58.1

1223

6411

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

12.4

58.0

109

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.9

58.0

200

364

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.3

57.9

134

143

S22

ICPC

Nail symptom/complaint

1.9

57.8

917

4378

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.9

57.8

890

4205

I95.2

ICD-10 Finland

Hypotension due to drugs

6.3

57.7

162

230

N18.0

ICD-10 Finland

End-stage renal disease

4.2

57.7

231

489

K99

ICPC

Cardiovascular disease other

2.6

57.7

445

1531

WX402

NOMESCO Finland

General anaesthesia

1.5

57.6

2563

16176

SPAT1325

SPAT

Vaccination

1.3

57.4

5863

42526

N05AF01

ATC

flupentixol; systemic

3.3

57.4

310

845

XCK00

NOMESCO Finland

Perimetry

1.8

57.4

1029

5126

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

57.3

524

1975

B01AB04

ATC

dalteparin; parenteral

2.0

57.3

749

3320

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

57.1

512

1911

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

57.0

1133

5833

B82

ICPC

Anaemia other/unspecified

2.7

57.0

410

1353

M01AB05

ATC

diclofenac; systemic, rectal

1.3

56.8

11428

90334

R63.1

ICD-10 Finland

Polydipsia

31.5

56.7

A12AA04

ATC

calcium carbonate; oral

3.5

56.6

282

722

F06.7

ICD-10 Finland

Mild cognitive disorder

2.7

56.6

401

1312

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

56.5

313

869

A13

ICPC

Concern/fear medical treatment

3.4

56.5

289

756

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

56.4

1651

9475

N05AL01

ATC

sulpiride; systemic

3.4

56.3

293

776

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

56.2

536

2061

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

56.0

562

2218

K91

ICPC

Cerebrovascular disease

3.8

56.0

250

585

P16

ICPC

Acute alcohol abuse

3.5

55.8

275

698

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.9

55.7

240

544

S09.9

ICD-10 Finland

Unspecified injury of head

4.3

55.6

218

453

R01AD08

ATC

fluticasone; nasal

1.3

55.4

4429

30960

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

4.1

55.3

226

488

F22.0

ICD-10 Finland

Delusional disorder

3.5

55.2

273

695

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

54.9

568

2274

U29

ICPC

Urinary symptom/complaint other

2.5

54.9

445

1574

Z43.5

ICD-10 Finland

Attention to cystostomy

7.2

54.9

139

171

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.2

54.9

307

859

F31

ICD-10 Finland

Bipolar affective disorder

4.0

54.8

230

509

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

54.7

389

1276

S76

ICPC

Skin infection other

2.0

54.7

767

3496

G72.9

ICD-10 Finland

Myopathy, unspecified

5.3

54.6

176

297

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

54.5

753

3411

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.6

54.5

263

657

L86

ICPC

Back syndrome with radiating pain

1.9

54.4

826

3878

W06

ICD-10 Finland

Fall involving bed

5.9

54.2

160

243

V03AE01

ATC

polystyrene sulfonate; oral

4.0

54.1

230

515

D21

ICPC

Swallowing problem

3.6

54.1

257

634

WX730

NOMESCO Finland

Conventional respirator

3.2

54.0

299

830

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

4.2

54.0

215

453

SPAT1243

SPAT

Psychiatric/psychological examination

2.5

54.0

441

1565

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.9

53.9

345

1059

B01AC07

ATC

dipyridamole; systemic

2.0

53.8

769

3532

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.9

53.6

352

1099

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.8

53.5

237

551

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

53.4

1229

6610

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.3

53.3

520

2024

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

53.1

368

1189

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

53.0

542

2159

Z11

ICPC

Compliance/being ill problem

5.9

52.9

155

233

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.7

52.9

1150

6082

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

52.9

912

4480

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.3

52.8

209

438

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.5

52.8

444

1603

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

52.7

1089

5672

R21

ICPC

Throat symptom/complaint

1.4

52.7

2999

19801

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.7

52.7

395

1335

-50

ICPC

Medication/prescr/renewal

2.1

52.7

666

2914

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

52.7

452

1649

L60.0

ICD-10 Finland

Ingrowing nail

2.1

52.6

654

2840

D07AB08

ATC

desonide; topical

1.6

52.6

1641

9565

SPAT1244

SPAT

Occupational therapy

4.3

52.6

206

428

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.3

52.5

286

785

N06DA04

ATC

galantamine; oral

3.0

52.5

321

956

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.8

52.5

186

349

XF606

NOMESCO Finland

Ortostatic test

6.5

52.4

143

196

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

52.4

641

2766

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

52.3

453

1660

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

52.3

496

1904

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

52.3

549

2213

L76

ICPC

Fracture: other

2.6

52.2

411

1431

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.8

52.2

138

181

R74

ICPC

Upper respiratory infection acute

1.3

52.1

4282

30012

WX290

NOMESCO Finland

Other blockade of nerve

1.3

52.0

6966

52194

-69

ICPC

Other reason for encounter NEC

2.1

52.0

640

2768

F48.0

ICD-10 Finland

Neurasthenia

11.0

51.9

103

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

51.9

447

1633

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

51.9

649

2827

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.6

51.8

410

1430

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

51.6

1197

6451

NHQ40

NOMESCO Finland

Amputation of toe

3.1

51.6

295

839

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.2

51.5

567

2336

R5599

NOMESCO Finland

Other rehabilitation service

2.5

51.5

435

1574

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

51.5

2081

12858

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.3

51.4

199

409

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.7

51.4

379

1269

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

51.3

1138

6054

WX212

NOMESCO Finland

Femoral plexus blockade

3.0

51.3

318

956

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

51.0

249

628

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.8

50.9

179

333

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.4

50.9

161

266

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.3

50.7

198

410

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

50.7

436

1591

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.6

50.7

383

1302

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.8

50.7

344

1097

N06AA04

ATC

clomipramine; systemic

3.1

50.5

296

856

WF004

NOMESCO Finland

Palliative radiotherapy

3.0

50.5

313

940

M54.1

ICD-10 Finland

Radiculopathy

2.2

50.5

559

2310

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

50.3

2191

13740

Z72.2

ICD-10 Finland

Drug use

7.9

50.3

120

135

XA400

NOMESCO Finland

EEG

7.6

50.2

123

144

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.4

49.9

467

1782

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

49.9

1418

8070

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

49.9

416

1496

Z01.7

ICD-10 Finland

Laboratory examination

1.5

49.8

1678

9952

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

49.8

810

3902

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

49.7

3673

25302

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

49.7

155

252

A06AH03

ATC

naloxegol; oral

4.5

49.6

187

374

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.9

49.6

N04BD01

ATC

selegiline; oral

3.1

49.6

285

814

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

49.5

3005

20043

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.2

49.5

533

2176

R63.0

ICD-10 Finland

Anorexia

11.0

49.5

XQ800

NOMESCO Finland

Prick test

1.7

49.4

1066

5624

AA400

NOMESCO Finland

Electroconvulsive therapy

4.7

49.3

175

329

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

49.3

427

1564

G44.8

ICD-10 Finland

Other specified headache syndromes

4.7

49.3

177

337

M01AB55

ATC

diclofenac, combinations; oral

1.7

49.3

1020

5314

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.5

49.2

395

1390

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

8.7

49.2

111

114

L04AX01

ATC

azathioprine; systemic

2.1

49.1

624

2735

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.5

49.1

152

245

L03AA02

ATC

filgrastim; parenteral

2.7

49.0

359

1199

C10AA03

ATC

pravastatin; oral

1.7

49.0

1082

5746

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

49.0

1536

8959

G04BD11

ATC

fesoterodine; oral

2.3

48.8

476

1854

M01AB01

ATC

indometacin; systemic, rectal

1.6

48.8

1243

6875

IGV01

NOMESCO Finland

Psychiatric network contact

5.0

48.7

165

295

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

48.7

587

2517

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

48.7

398

1414

J05AB01

ATC

aciclovir; systemic

1.4

48.6

3129

21072

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.8

48.4

218

515

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.2

48.3

193

409

N05AE04

ATC

ziprasidone; systemic

5.7

48.2

145

226

N06AX18

ATC

reboxetine; oral

3.7

48.1

222

535

H53.4

ICD-10 Finland

Visual field defects

2.8

48.0

336

1091

SPAT1153

SPAT

Removal of sutures

1.3

48.0

5059

36657

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

48.0

12136

97525

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

48.0

4275

30263

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.8

47.8

317

995

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.0

47.8

201

447

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

9.0

47.5

105

104

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.1

47.5

158

277

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

47.5

511

2084

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.0

47.5

138

206

L13

ICPC

Hip symptom/complaint

1.4

47.5

2258

14401

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

47.5

545

2289

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.4

47.3

415

1533

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.1

47.3

135

197

JAH01

NOMESCO Finland

Laparoscopy

2.0

47.2

633

2833

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.2

47.2

261

725

WX320

NOMESCO Finland

Spinalanesthesy

1.3

47.0

3572

24690

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

6.4

47.0

130

182

N06AB08

ATC

fluvoxamine; oral

2.3

46.9

449

1731

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.0

46.9

641

2892

R03BA08

ATC

ciclesonide; inhalant

1.6

46.8

1168

6418

T74.1

ICD-10 Finland

Physical abuse

3.0

46.8

280

821

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

46.8

1140

6226

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.7

46.7

340

1131

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

46.6

284

843

A91

ICPC

Abnormal result investigation NOS

2.0

46.5

647

2940

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

46.4

535

2253

N06BA07

ATC

modafinil; oral

8.7

46.3

104

106

A01AB04

ATC

amphotericin B; local oral

1.9

46.2

710

3348

F05.1

ICD-10 Finland

Delirium superimposed on dementia

6.2

46.2

130

186

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

46.2

617

2759

130

Kela drug reimbursment

Malignant tumour

1.6

46.2

1241

6957

XX3XW

NOMESCO Finland

6.1

46.1

131

190

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.6

46.1

140

221

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.6

46.0

223

560

V03AA01

ATC

2.9

46.0

293

898

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

46.0

1395

8064

C01BD01

ATC

amiodarone; systemic

2.3

45.9

465

1845

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

45.9

282

843

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

45.9

342

1152

A06

ICPC

Fainting/syncope

3.8

45.9

202

468

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

45.8

316

1019

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.6

45.8

216

531

N05BA09

ATC

clobazam; oral

8.3

45.8

106

114

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

45.6

326

1073

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.1

45.6

568

2468

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.8

45.6

317

1025

G40.89

ICD-10 Finland

Other epilepsy

9.9

45.5

E000003

ATC

1.9

45.5

698

3293

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.9

45.5

295

915

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.3

45.2

443

1728

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

45.2

865

4398

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

45.1

640

2929

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

45.1

10875

86646

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.9

45.1

195

445

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

45.1

296

923

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.4

45.1

398

1476

J01FA09

ATC

clarithromycin; systemic

1.3

45.0

4852

35207

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.1

45.0

184

399

R95

ICPC

Chron obstructive pulmonary disease

2.3

44.9

430

1658

S00.8

ICD-10 Finland

Superficial injury of other parts of head

3.1

44.9

257

732

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

44.9

1915

11942

K28

ICPC

Limited function/disability (K)

2.7

44.8

325

1080

S19

ICPC

Skin injury other

2.0

44.8

584

2587

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

44.7

723

3475

S10

ICPC

Boil/carbuncle

1.8

44.7

809

4039

L08

ICPC

Shoulder symptom/complaint

1.4

44.6

2763

18462

N05AB01

ATC

dixyrazine; systemic

3.4

44.6

229

603

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

44.5

288

889

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

44.5

1018

5460

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.0

44.5

275

827

C01CA24

ATC

epinephrine; parenteral

1.8

44.4

863

4407

M35.7

ICD-10 Finland

Hypermobility syndrome

3.6

44.4

210

518

Y96.9

ICD-10 Finland

Unspecified type of accident

3.0

44.3

277

837

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.9

44.3

670

3142

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

44.3

840

4255

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.4

44.2

229

607

L84

ICD-10 Finland

Corns and callosities

2.2

44.1

492

2041

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

44.1

179

386

ZZA00

NOMESCO Finland

Split skin graft

2.3

43.9

442

1747

G30

ICD-10 Finland

Alzheimer disease

3.9

43.9

190

434

SPAT1285

SPAT

Provision of consultation response

1.8

43.9

802

4014

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

43.9

249

704

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

4.7

43.8

157

299

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.9

43.8

190

435

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.4

43.8

138

228

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.8

43.7

105

120

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.0

43.7

182

402

S01

ICPC

Pain/tenderness of skin

2.0

43.6

616

2816

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

43.3

1474

8754

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

43.3

277

852

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.3

43.2

421

1638

I47.2

ICD-10 Finland

Ventricular tachycardia

2.6

43.2

341

1191

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.3

43.2

229

618

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

43.1

1611

9769

E87.2

ICD-10 Finland

Acidosis

5.9

43.1

126

190

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22082

158808

1.86

322.35

6.3

4.5

2.0

2.2

mu/l

0.48

20536

144040

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1344

3547

3.27

319.42

2.2

2.1

0.0

g/l

0.59

1191

3207

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1324

3488

3.27

315.50

2.3

2.1

0.0

g/l

0.00

1186

3196

(3023103) Potassium [Moles/volume] in Serum or Plasma

24057

178401

2.10

315.02

34.1

13.4

4.0

mmol/l

6.11

23613

172588

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2484

9186

2.38

311.68

7.4

6.6

24.9

24.5

mmol/l

4.28

2362

8518

(40767503) Oxygen content in Capillary blood by calculation

1156

2814

3.53

311.29

3.1

2.4

16.1

16.4

1.70

588

1560

(3028271) Lactate [Moles/volume] in Capillary blood

931

1950

4.08

309.78

2.5

1.6

1.7

mmol/l

0.01

914

1895

(3034860) Kappa light chains.free [Mass/volume] in Serum

1507

4338

3.01

309.64

2.9

3.1

99.5

62.1

mg/l

0.47

1203

3544

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1471

4180

3.04

309.05

2.8

3.1

15.0

3.2

ratio

0.85

325

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1503

4328

3.00

308.61

2.9

3.1

41.6

44.5

mg/l

0.38

1197

3535

(3044640) Blood type and Crossmatch panel - Blood

9748

51641

1.89

307.65

3.2

2.1

—

(40768797) Stomach Pathology biopsy report

4722

21023

2.06

307.65

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1198

2382

4.34

307.65

1.4

18.1

24.5

e6/l

0.41

937

1821

(3014111) Lactate [Moles/volume] in Serum or Plasma

4545

12128

3.55

307.65

7.1

6.7

1.4

1.3

mmol/l

3.37

4375

11683

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1415

3810

3.21

307.65

2.2

2.1

0.0

g/l

0.53

1258

3458

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1530

2542

5.26

307.65

1.5

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16733

109309

1.72

307.65

4.3

2.7

59.8

45.5

u/l

44.57

15615

101136

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1563

4450

3.04

307.65

2.2

0.9

1.0

g/l

0.46

1311

3739

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1818

5252

3.02

307.65

2.1

7.5

7.3

g/l

2.74

1346

3808

(3032080) INR in Blood by Coagulation assay

13820

63903

2.64

307.65

12.7

8.2

1.3

inr

0.30

4050

17728

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3395

7513

4.16

307.65

1.7

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3597

11565

2.84

307.65

2.3

2.4

65.3

66.9

g/l

23.34

3219

10370

(3006504) Eosinophils/100 leukocytes in Blood

14738

74592

2.42

307.65

7.4

5.3

2.7

2.9

31.55

13873

68705

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2852

9373

2.72

307.65

4.4

3.3

5.2

5.1

kpa

0.30

2665

8617

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6306

20279

3.07

307.65

3.1

2.3

21.6

22.8

7.82

5438

17050

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2656

9080

2.59

307.65

9.5

8.7

0.7

0.23

2628

9030

(3019309) Folate [Moles/volume] in Red Blood Cells

8259

29756

2.89

307.65

2.0

1.7

1139.7

1156.5

nmol/l

0.81

6366

21910

(3019069) Monocytes/100 leukocytes in Blood

14814

75041

2.42

307.65

7.7

5.5

8.7

8.6

5.47

13969

69504

(3009261) Glucose [Presence] in Urine by Test strip

14160

83490

1.87

307.65

5.3

3.3

0.0

estimate

0.12

2900

14550

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10654

44983

2.60

307.65

3.8

2.7

1971.6

1428.1

ng/l

19.04

9158

38238

(3027945) Reticulocytes/100 erythrocytes in Blood

5007

16698

2.84

307.65

2.7

2.3

1.9

1.7

15.86

4376

14555

(3021589) Normoblasts [#/volume] in Blood

12767

73178

1.86

307.65

13.7

8.2

0.0

e9/l

0.96

10542

59441

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7889

21892

3.82

307.65

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2746

8948

2.73

307.65

4.3

3.3

1.9

1.7

mmol/l

1.16

2078

6517

(3021960) Folate [Moles/volume] in Serum or Plasma

8992

37240

2.51

307.65

1.8

1.5

19.2

20.7

nmol/l

17.75

7956

31353

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7529

38947

1.85

307.65

3.1

2.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

11760

53738

2.45

307.65

3.6

3.0

2.3

2.4

mmol/l

28.04

10228

46132

(3026782) Osmolality of Urine

8435

29805

2.97

307.65

3.8

2.4

526.2

558.8

mosm/kgh2o

33.94

7370

24895

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1813

5247

3.01

307.65

2.1

—

(3035350) Ketones [Presence] in Urine by Test strip

14124

82183

1.90

307.65

5.2

3.3

0.0

estimate

1.54

2927

14613

(3027801) Oxygen [Partial pressure] in Arterial blood

4898

16633

2.77

307.65

7.4

6.9

11.7

12.5

kpa

21.82

4649

15848

(3037467) Urinalysis macro (dipstick) panel - Urine

19590

116639

2.44

307.65

6.5

3.8

—

(1616796) Gas panel - Central venous blood

1364

2995

3.94

307.65

3.6

3.4

—

(3042936) Bacteria identified in Isolate by Culture

5184

20866

2.32

307.65

2.4

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8257

28601

3.02

307.65

5.7

3.2

217.5

627.6

ng/l

11.59

6690

22346

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13104

67397

2.20

307.65

2.6

2.1

76.1

1447.6

nmol/l

0.50

11754

59858

(3018095) Leukocytes [#/volume] in Urine

12531

56894

2.55

307.65

5.5

3.2

109.0

108.6

e6/l

0.01

9809

38438

(3019198) Lymphocytes [#/volume] in Blood

15826

81883

2.47

307.65

7.2

5.1

1.8

2.0

e9/l

11.06

14061

71078

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12748

78819

1.66

307.65

5.0

3.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

5294

18288

2.75

307.65

8.2

6.4

103.9

104.7

mmol/l

21.42

5178

17866

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1530

2542

5.26

307.65

1.5

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4901

16642

2.77

307.65

7.4

6.9

5.1

kpa

0.37

4659

15856

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2634

9126

2.56

307.65

9.5

8.6

1.4

1.3

3.83

2607

9070

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1833

5739

2.78

307.65

1.5

11.2

17.3

u/ml

1.14

152

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1814

5235

3.02

307.65

2.1

3.8

g/l

0.62

1309

3614

(3013115) Eosinophils [#/volume] in Blood

15939

82384

2.49

307.65

7.5

5.3

0.2

e9/l

17.73

14143

71191

(3000991) Gas panel - Venous blood

4251

11791

3.38

307.65

8.9

7.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1033

1462

6.08

307.65

5.8

4.8

364.1

367.4

umol/l

0.24

911

1217

(3027315) Oxygen [Partial pressure] in Blood

1334

2961

3.90

307.65

4.6

3.6

8.7

8.6

kpa

0.44

1297

2883

(3007853) Bacteria identified in Skin by Aerobe culture

4488

17881

2.31

307.65

2.1

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8288

31675

2.70

307.65

2.2

1.6

1.3

mg/l

0.53

6417

24113

(3002032) Base excess in Venous blood by calculation

5080

12737

3.86

307.65

5.3

3.3

2.0

1.8

mmol/l

2.85

4320

10204

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21182

128387

2.71

307.65

10.4

6.2

83.2

78.0

u/l

34.38

20214

119547

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2344

6165

3.37

307.65

3.9

2.5

0.7

0.37

2298

5885

(3022096) Basophils/100 leukocytes in Blood

14457

72127

2.44

307.65

7.3

5.3

0.6

0.7

42.29

13609

66473

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13544

58781

2.84

307.65

5.9

3.0

54.3

75.4

ng/l

0.92

10087

39110

(3018010) Neutrophils/100 leukocytes in Blood

14771

76349

2.34

307.65

7.3

5.2

59.1

57.1

65.22

13906

70689

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4730

16784

2.63

307.65

3.3

2.4

8.6

8.8

umol/l

0.29

4030

14521

(3019550) Sodium [Moles/volume] in Serum or Plasma

24055

177899

2.12

307.65

33.9

13.3

139.1

139.7

mmol/l

224.78

23637

172448

(3004119) Hemoglobin [Mass/volume] in Venous blood

2870

8519

3.02

307.65

4.7

2.9

126.1

129.8

g/l

13.58

2807

8323

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

13174

56241

2.85

307.65

4.7

2.9

—

0.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2344

7764

2.66

307.65

1.8

1.3

1.4

g/l

0.94

2120

6995

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14024

68192

2.48

307.65

2.5

1.9

91.9

96.2

pmol/l

21.73

7859

34620

(3006315) Basophils [#/volume] in Blood

15633

79529

2.51

307.65

7.1

5.1

0.0

e9/l

9.03

13641

67634

(3019060) Gas panel - Arterial blood

2725

9520

2.54

307.65

4.8

4.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3144

8546

3.34

307.65

7.1

6.9

25.0

24.8

mmol/l

3.05

3104

8466

(3003396) Base excess in Arterial blood by calculation

4920

16655

2.79

307.65

7.4

6.8

1.3

1.0

mmol/l

5.59

3950

12987

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14081

71127

2.35

307.65

3.7

2.6

148.5

118.0

ug/l

20.26

12986

65469

(3026008) Bacteria identified in Urine by Culture

12079

48186

2.96

307.65

4.5

2.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1708

2368

6.35

307.65

3.2

2.3

32.9

33.6

umol/l

0.40

1400

1972

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3908

13610

2.63

307.65

2.4

2.1

0.2

g/l

23.16

3540

12648

(3033658) Prothrombin time (PT) actual/Normal

8870

39693

2.28

307.65

6.0

3.3

84.8

89.8

55.87

8643

38669

(3001604) Monocytes [#/volume] in Blood

15563

79142

2.50

307.65

7.1

5.1

0.6

e9/l

14.82

13591

67298

(3023368) Bacteria identified in Blood by Culture

11708

38454

3.71

307.65

6.0

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3964

9493

3.90

307.65

1.9

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2650

9089

2.58

307.65

9.6

8.8

93.4

94.0

4.89

2632

9058

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7140

28524

2.47

307.65

3.4

2.8

2.5

mmol/l

10.31

6107

24683

(42870588) Differential panel, method unspecified - Blood

11685

53421

2.45

307.65

6.8

5.2

—

(3015736) pH of Urine

11552

63567

1.90

307.65

4.7

3.1

5.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3336

11217

2.69

307.65

4.3

3.5

101.1

87.8

ng/l

7.56

2840

9559

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6971

26687

2.58

307.65

3.8

2.5

1.3

1.1

e6/l

0.97

4104

14825

(36304419) Bacteria [Presence] in Urine

10328

42460

2.66

307.65

4.5

2.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10302

51143

2.09

307.65

3.9

2.9

34.6

33.5

u/l

0.49

9699

48301

(3022948) Iron [Moles/volume] in Serum or Plasma

7106

23942

3.00

307.65

2.9

2.2

12.0

13.3

umol/l

36.06

6540

22035

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1723

4908

3.06

307.65

2.1

10.4

10.3

g/l

0.31

1435

4010

(3021601) Nitrite [Presence] in Urine by Test strip

14040

82561

1.87

307.65

7.2

4.4

0.0

estimate

2.81

2978

14899

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23944

172973

2.31

307.65

30.1

11.0

23.7

24.3

mg/l

2.94

21444

132638

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5797

14670

3.92

307.65

2.2

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17482

79040

3.37

307.65

9.0

5.6

1.2

mmol/l

9.29

14964

65851

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3874

13822

2.56

307.65

8.3

7.6

119.4

121.5

g/l

7.13

3779

13287

(3027273) Bicarbonate [Moles/volume] in Venous blood

2172

6863

2.78

307.65

5.0

2.9

25.3

25.2

mmol/l

0.90

2112

6658

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2485

7560

2.91

307.65

9.1

9.0

24.5

24.3

mmol/l

2.55

2288

7030

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7156

35028

1.95

307.65

1.9

1.6

26160997.9

31701767.2

pmol/l

0.35

5967

28554

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6664

21902

3.04

307.65

2.9

2.2

2.4

g/l

42.61

6129

20074

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6686

24740

2.66

307.65

4.0

2.6

3.0

2.7

e6/l

0.89

3831

12977

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4257

13343

2.97

307.65

3.3

2.2

36.2

51.1

u/l

1.14

3654

11313

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3675

12807

2.61

307.65

3.6

2.7

290.3

202.1

ng/l

13.43

3326

11711

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7280

22584

3.31

307.65

3.8

2.9

0.8

mmol/l

18.81

6765

20837

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2395

6289

3.38

307.65

3.9

2.5

1.3

1.2

2.52

2387

6266

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5932

18629

3.12

307.65

6.6

4.9

1.1

1.0

mmol/l

2.04

5484

17153

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16000

71550

3.11

307.65

8.1

5.1

1.2

mmol/l

21.80

14894

63596

(3024928) Oxygen saturation in Venous blood

1265

2786

3.92

307.65

3.7

3.0

—

(3037522) Nuclear Ab [Titer] in Serum

4611

19746

2.14

307.65

1.5

1.3

471.3

568.8

titre

3.14

905

4080

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3060

6303

4.43

307.65

5.4

3.6

24.2

24.1

mmol/l

2.07

2844

5653

(3013826) Glucose [Moles/volume] in Serum or Plasma

18686

94405

3.09

307.65

7.2

3.9

6.8

6.7

mmol/l

3.22

17976

86896

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1198

2385

4.33

307.65

1.5

1.4

3238.1

3006.1

e6/l

0.03

977

1919

(3005719) IgG [Mass/volume] in Serum or Plasma

3011

9848

2.74

307.65

2.6

2.5

10.6

10.8

g/l

1.29

2737

8916

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1697

4899

3.01

307.65

2.1

3.2

3.0

g/l

10.09

1331

3712

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12410

44355

3.46

307.65

2.8

1.9

222.2

211.2

u/l

0.32

11792

41052

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3718

12399

2.74

307.65

3.0

2.1

5.8

7.8

ug/l

6.38

3102

10698

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2324

6396

3.22

307.65

1.8

1.6

1.5

g/l

3.37

2000

5403

(40758558) Short blood count panel - Blood

8660

39520

2.21

307.65

9.1

5.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1334

2945

3.92

307.65

4.6

3.6

5.0

kpa

0.73

1297

2868

(3010421) pH of Blood

1480

3445

3.73

307.65

4.6

3.5

7.4

0.46

1298

2866

(3012501) Base excess in Blood by calculation

1334

2943

3.92

307.65

4.6

3.6

2.5

mmol/l

0.04

933

1940

(3003181) Sodium [Moles/volume] in Urine

1182

2075

4.92

307.65

1.6

1.3

59.6

64.7

mmol/l

3.38

961

1631

(3024354) Oxygen [Partial pressure] in Venous blood

4260

10527

3.81

307.65

4.6

2.8

4.5

4.6

kpa

0.23

4103

10179

(3031040) Bacteria [#/volume] in Urine by Automated count

19686

111281

2.73

307.65

7.3

3.9

1592.7

1485.7

e6/l

0.10

290

1632

(3052851) Hemolysis interference index of Serum or Plasma

1589

4349

3.17

307.65

3.8

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2992

9454

2.84

307.65

2.2

—

(3018418) pH of Serum or Plasma

11443

45712

2.88

307.65

5.2

3.4

7.4

1.29

2180

8298

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6507

21997

2.93

307.65

2.5

1.9

30.2

29.8

3.45

6313

21297

(3002030) Lymphocytes/100 leukocytes in Blood

15009

77460

2.38

307.65

7.5

5.3

25.7

28.2

122.57

14099

71353

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5100

12781

3.86

307.65

5.3

3.3

5.9

5.8

kpa

3.36

4948

12406

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1948

4925

3.47

307.65

2.1

1.8

2.0

2.4

ug/l

0.90

1669

4270

(3002582) Erythrocytes [#/volume] in Urine

11565

47594

2.79

307.65

4.7

2.9

56.7

112.3

e6/l

6.49

9404

35341

(3000850) Epithelial cells [#/volume] in Urine

8420

32303

2.70

307.65

3.4

2.3

5.9

5.5

e6/l

1.00

7549

27840

(3013650) Neutrophils [#/volume] in Blood by Automated count

17311

93003

2.52

307.65

11.6

7.5

4.4

4.1

e9/l

37.39

15346

79796

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5788

14731

3.89

307.65

2.2

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1345

2714

4.29

307.65

1.3

542.6

521.0

mg/l

0.25

1280

2572

(3022217) INR in Platelet poor plasma by Coagulation assay

5324

20012

2.51

307.65

27.7

25.6

1.4

inr

0.39

645

2567

(3044290) Cell count panel - Cerebral spinal fluid

1115

2232

4.30

307.65

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3760

15952

2.12

307.65

5.2

2.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2193

4170

4.68

307.65

2.3

2.2

570.4

604.3

ug/l

0.10

2042

3877

(3013707) Erythrocyte sedimentation rate by Westergren method

19601

124160

2.14

307.65

5.1

3.6

15.5

11.8

mm/h

154.33

18235

113642

(3023520) Reticulocytes [#/volume] in Blood

3666

12295

2.72

307.65

2.8

2.3

71.2

68.4

e9/l

3.83

2692

9225

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5042

11748

4.16

307.65

2.3

2.2

375.9

382.5

nmol/l

1.13

4638

10728

(3030467) Casts [#/volume] in Urine by Automated count

10775

43570

2.76

307.65

4.6

2.8

0.5

0.4

e6/l

1.45

8638

31742

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17031

81582

2.99

307.65

7.7

5.1

11.4

11.8

umol/l

3.32

16202

76754

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1889

3449

4.83

307.65

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3227

8032

3.66

307.65

2.1

1.5

—

(3009343) pH of Capillary blood

2826

9255

2.72

307.65

4.4

3.3

7.4

0.15

444

1102

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19661

131030

1.91

307.65

5.1

3.8

14.9

14.8

pmol/l

7.98

18095

117895

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10386

39771

2.91

307.65

2.7

2.1

3.0

2.9

mg/l

1.78

8901

33574

(3016502) Oxygen saturation in Arterial blood

4265

14932

2.64

307.65

7.8

7.2

95.3

95.7

2.76

4116

14360

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4955

16010

2.93

307.65

3.9

3.6

243.2

243.5

u/l

0.04

4657

15031

(3020779) Urea [Moles/volume] in Serum or Plasma

4259

12573

3.16

307.65

8.2

5.9

10.4

10.0

mmol/l

2.84

4023

11860

(3024561) Albumin [Mass/volume] in Serum or Plasma

15104

68329

2.90

307.65

5.8

4.1

34.1

35.7

g/l

192.87

14030

62757

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1470

4056

3.14

307.65

2.2

2.0

35.9

38.3

g/l

32.23

1240

3399

(3012544) pH of Venous blood

5173

13296

3.77

307.65

5.2

3.3

7.4

0.23

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11413

47998

2.69

307.65

3.3

2.2

55.2

60.1

u/l

14.67

10696

43824

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1187

2351

4.35

307.65

1.3

1.2

3.8

mmol/l

0.88

1102

2211

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1763

4556

3.38

307.65

3.2

2.8

0.3

0.4

u/ml

1.01

1055

2498

(3011397) Hemoglobin [Presence] in Urine by Test strip

7293

38518

1.79

307.65

4.8

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

6124

29667

1.93

307.65

1.6

1.4

2.5

2.4

g/l

4.61

3686

17287

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2093

6279

2.93

307.65

6.0

3.4

49.5

47.0

4.42

2074

6201

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1103

2623

3.61

307.44

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6664

35272

1.76

307.17

1.4

1.3

1.4

1.8

u/ml

1.90

1663

9284

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1400

3892

3.11

305.24

1.5

1.4

269.3

272.2

ug/g

0.18

834

2238

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3099

12713

2.16

303.58

4.8

3.2

1.2

mmol/l

7.14

2754

10775

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2521

9536

2.33

300.03

3.1

3.4

4.3

4.5

pmol/l

14.14

2208

8492

(3028626) Oxygen [Partial pressure] in Capillary blood

1275

3441

3.19

291.81

3.7

3.1

8.2

8.3

kpa

2.09

1194

3221

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1057

2561

3.54

286.36

1.7

1.4

—

(3044889) 12 lead EKG panel

17307

118268

1.61

280.31

4.9

3.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

986

2318

3.64

279.21

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

769

1524

4.30

274.67

2.4

1.6

89.6

89.9

0.51

757

1500

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

586

925

5.37

272.80

1.5

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6378

34403

1.71

269.11

5.3

3.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

934

2179

3.66

267.34

1.2

1.3

290.1

261.6

u/ml

1.80

634

1349

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10414

63671

1.59

267.06

5.8

3.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1262

3566

3.04

267.05

3.2

3.0

24.9

24.8

mmol/l

0.32

1126

3132

(3025941) Bacteria identified in Stool by Culture

2201

8301

2.32

262.31

1.4

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2169

8151

2.32

260.58

9.9

9.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7425

42019

1.65

259.64

3.0

2.4

4347.5

5394.6

umol/l

1.29

6278

36047

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1246

3560

3.01

258.55

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

971

2382

3.49

257.92

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2503

10043

2.19

256.96

2.5

2.3

23.9

24.6

au/ml

0.07

614

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

822

1805

3.88

256.23

1.7

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

3961

18820

1.88

254.43

2.2

2.3

145.3

127.2

ug/g

1.41

3119

14559

(3035637) Corticotropin [Mass/volume] in Plasma

754

1566

4.10

253.35

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1276

3748

2.93

252.11

1.7

1.6

0.2

g/l

0.41

1194

3543

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1306

3892

2.89

251.41

1.7

1.6

1.2

g/l

1.93

1225

3692

(3013512) EKG study

8146

47500

1.61

250.80

5.6

3.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1322

3973

2.86

250.62

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

958

2376

3.45

250.19

1.4

16.3

21.7

u/ml

0.68

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3774

17755

1.90

249.49

2.0

1.6

1.4

41.91

3214

15614

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

885

2107

3.58

245.73

5.5

5.1

6725.7

792.6

iu/ml

0.66

139

334

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1420

4486

2.73

245.13

1.6

1.5

143.2

232.1

titre

1.60

200

(40760888) Immunoglobulin light chains.free panel - Serum

1137

3189

3.06

243.37

2.8

3.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2295

9094

2.20

242.40

1.3

40.2

51.8

au/ml

1.00

398

(3022313) Gas panel - Capillary blood

1885

6885

2.38

240.93

4.8

3.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1601

5431

2.55

239.80

1.8

38.4

38.7

u/l

0.25

1381

4755

(3017143) Hepatitis C virus Ab [Presence] in Serum

3578

16766

1.90

238.60

1.7

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1229

3658

2.88

236.90

1.4

1.5

17.6

13.5

iu/ml

0.29

(3018405) Lactate [Moles/volume] in Arterial blood

1487

4893

2.62

236.87

4.5

3.9

1.4

mmol/l

0.63

1452

4811

(3023410) Appearance of Cerebral spinal fluid

592

1082

4.64

233.44

1.6

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

914

2305

3.38

232.50

4.1

2.7

60.4

65.0

6.73

909

2298

(3021901) Oxygen saturation in Capillary blood

981

2587

3.24

232.49

2.9

2.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

885

2186

3.45

232.43

1.4

111.1

112.2

u/ml

0.08

216

484

(3020891) Body temperature

1617

5594

2.50

232.31

5.9

4.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1674

5887

2.46

232.24

2.5

1.7

—

(3008295) Osmolality of Serum or Plasma

626

1204

4.41

231.98

1.5

1.4

278.9

280.3

mosm/kgh2o

0.61

456

939

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1713

6174

2.40

225.09

5.4

4.6

1.7

1.6

0.11

1640

5782

(3036489) Thrombin time

1533

5251

2.52

224.71

2.4

1.8

22.2

21.6

1.60

1364

4568

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1551

5352

2.50

223.84

2.4

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

7542

44239

1.58

220.53

5.9

3.6

0.0

estimate

0.25

2826

14300

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3476

16529

1.86

220.16

3.4

3.9

33.8

22.3

ug/l

1.06

2851

13365

(46235355) HIV 1 and 2 tests - Meaningful Use set

5160

27603

1.69

217.97

1.9

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1678

6084

2.38

217.40

5.5

4.6

0.9

1.25

1608

5690

(3016038) Potassium [Moles/volume] in Urine

474

764

5.24

215.64

1.4

1.2

33.1

36.1

mmol/l

1.64

402

650

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

696

1536

3.85

215.24

2.9

2.4

1153.4

732.3

u/ml

0.40

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

773

1837

3.58

215.02

1.3

1.7

2.3

nmol/l

0.17

734

1764

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

667

1455

3.89

209.59

1.6

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1647

6026

2.36

208.88

5.1

3.5

24.8

mmol/l

0.04

1537

5528

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

764

1843

3.53

207.79

1.3

0.3

0.2

nmol/l

0.00

125

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15333

105438

1.49

207.28

3.6

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1530

5450

2.42

205.86

1.3

1.2

0.7

1.0

u/ml

0.81

131

474

(3017181) Myelocytes/100 leukocytes in Blood

2766

12474

1.94

204.84

4.2

3.7

0.9

0.04

950

3005

(3016018) Differential panel - Cerebral spinal fluid

582

1184

4.16

200.74

1.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1256

4141

2.60

198.65

2.9

2.2

3.6

g/l

0.58

1197

3925

(3037756) Immunofixation for Serum or Plasma

981

2849

2.94

197.15

1.5

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

568

1160

4.15

194.91

1.1

23.3

79.5

au/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

1265

4227

2.57

194.63

4.8

4.2

3.9

mmol/l

1.09

1173

3959

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

703

1677

3.56

194.35

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

779

2016

3.29

189.98

1.5

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

662

1550

3.62

188.08

6.6

5.7

12.2

11.7

mg/l

1.45

604

1425

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1216

4078

2.55

185.57

1.8

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1017

3117

2.79

185.16

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7371

44487

1.52

182.68

5.1

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1332

4722

2.42

180.63

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1047

3309

2.70

179.75

1.9

12.6

10.8

mg/l

2.91

948

3073

(3002179) Metamyelocytes/100 leukocytes in Blood

2491

11330

1.92

178.60

4.0

3.5

0.7

0.6

0.47

658

2179

(3021440) Promyelocytes/100 leukocytes in Blood

2588

11975

1.89

175.99

4.3

3.7

0.1

0.49

866

2814

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

692

1745

3.36

175.73

1.5

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

755

2037

3.15

171.97

4.1

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

19647

144294

1.49

171.70

34.6

14.0

14.1

13.6

204.38

19335

140810

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

546

1193

3.87

171.08

1.7

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

342

504

5.71

170.93

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1225

4308

2.43

168.86

2.6

2.1

91.0

91.1

0.05

1152

3993

(3019150) Specific gravity of Urine by Refractometry

6136

36167

1.53

167.02

5.6

3.7

1.0

kg/l

0.26

934

5681

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1062

3514

2.58

166.34

2.5

2.1

127.3

130.1

g/l

2.87

832

2518

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

407

724

4.74

165.63

1.1

1.5

9.0

nmol/l

2.43

149

(3014765) Yersinia sp identified in Stool by Organism specific culture

1215

4299

2.42

165.21

1.3

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

423

780

4.57

164.95

1.3

1.2

2.0

2.1

mmol/l

1.00

388

725

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

345

531

5.47

164.86

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

508

1082

3.97

164.81

1.0

1.1

—

(40761535) Cells panel - Urine sediment

2720

13049

1.82

164.33

4.5

3.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1147

3968

2.47

163.72

2.8

2.2

205.2

187.0

7.77

1086

3748

(42529406) Shigella sp [Presence] in Stool by Culture

1213

4309

2.41

163.48

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1200

4269

2.40

161.18

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

509

1105

3.89

160.89

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

605

1488

3.44

159.62

1.5

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

327

496

5.55

158.67

2.3

1.7

122.1

161.5

umol/l

1.00

186

249

(3047181) Lactate [Moles/volume] in Blood

1267

4662

2.33

157.71

5.8

5.4

1.3

mmol/l

0.56

1142

4111

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21467

161454

1.52

157.55

26.3

11.0

77.5

80.5

ml/min/173m2

60.68

18904

129877

(3027456) Digoxin [Moles/volume] in Serum or Plasma

944

3053

2.63

154.68

3.6

3.0

0.8

nmol/l

1.35

741

2345

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

617

1583

3.30

152.41

1.5

1.3

—

(3025159) Blasts/100 leukocytes in Blood

2401

11364

1.83

150.90

4.3

3.7

0.1

0.3

0.41

716

2427

(3000494) Fungus identified in Specimen by Culture

3432

18009

1.67

150.27

1.6

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

997

3370

2.52

149.27

5.5

2.7

1.6

mmol/l

0.19

977

3304

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

330

544

5.10

146.47

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23865

184647

1.64

144.94

32.3

13.5

83.9

76.9

umol/l

93.57

23847

184560

(3020191) Ethanol [Moles/volume] in Serum or Plasma

443

943

3.96

143.82

1.8

1.2

1.4

promille

0.92

341

734

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1372

5421

2.17

143.74

2.9

3.2

1400.1

1197.0

u/ml

0.16

1150

4625

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

439

930

3.98

143.45

1.2

1.1

36.1

45.0

mg/l

3.61

358

775

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

899

2951

2.59

142.88

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1278

4940

2.21

141.31

1.7

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

900

2976

2.57

140.92

1.5

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1844

8199

1.94

140.09

3.5

2.5

0.3

e6/l

0.22

1811

7984

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1900

8541

1.92

139.71

2.5

2.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

373

713

4.41

139.20

16.5

17.2

3372.9

1424.2

nmol/l

0.50

358

685

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

459

1029

3.76

138.73

1.6

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

422

893

3.98

138.11

1.1

251.5

276.5

mg/l

1.42

368

791

(3033705) Calcium.ionized [Moles/volume] in Venous blood

645

1805

3.03

137.99

3.7

2.0

—

(4198724)

295

464

5.34

137.80

3.3

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

410

865

3.99

134.72

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

796

2533

2.67

134.52

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20897

157816

1.45

133.52

7.0

5.6

41.1

39.6

mmol/mol

67.81

19276

144997

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

356

678

4.42

133.47

11.9

12.1

790.6

842.4

nmol/l

0.95

344

656

(40761511) CBC panel - Blood by Automated count

23508

181931

1.58

132.75

26.0

11.1

—

(4027681)

358

689

4.37

132.49

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2227

10706

1.80

132.21

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4608

26708

1.53

131.13

1.4

1.2

39.1

39.4

iu/ml

0.01

1327

8364

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

402

859

3.94

129.85

1.7

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2225

10753

1.79

129.67

1.3

1.2

113.7

152.0

iu/ml

4.46

726

4039

(3024980) IgG subclass 4 [Mass/volume] in Serum

687

2064

2.82

129.48

1.5

0.7

0.8

g/l

0.96

530

1565

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

361

715

4.25

128.85

1.5

1.4

5.2

5.8

u/l

1.22

297

599

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1038

3825

2.31

128.39

4.2

3.2

1.8

1.5

mg/l

16.99

937

3468

(3034770) Mitochondria Ab [Titer] in Serum

1030

3801

2.31

126.97

1.2

547.9

1051.9

titre

2.13

120

(3007566) Smooth muscle Ab [Titer] in Serum

1037

3841

2.30

126.74

1.3

1.2

116.4

138.8

titre

0.37

337

(44790047)

494

1242

3.36

125.95

1.5

1.4

—

(44790049)

494

1242

3.36

125.95

1.5

1.4

—

(44790048)

494

1243

3.35

125.79

1.5

1.4

—

(44806118)

494

1243

3.35

125.79

1.5

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

916

3236

2.41

124.56

5.9

2.7

7.7

mmol/l

0.02

899

3180

(40761536) Microorganisms panel - Urine sediment

2698

14023

1.67

120.73

6.0

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4063

23460

1.52

116.16

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

630

1918

2.78

115.81

1.8

1.5

59.8

59.5

mu/l

0.02

547

1719

(36660697) Celiac disease serology panel - Serum

2490

12836

1.68

114.63

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

8084

53160

1.38

114.59

3.5

3.1

7.0

7.6

mmol/l

23.92

6664

44280

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23770

185575

1.55

113.93

15.3

8.9

25.2

25.7

u/l

2.32

23074

177835

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

769

2618

2.49

113.18

1.2

187.1

145.8

titre

0.27

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

376

846

3.74

113.08

2.6

3.5

112.9

134.1

nmol/l

0.55

363

834

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1084

4293

2.15

112.46

1.8

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1251

5236

2.04

112.23

1.7

1.6

344.8

307.9

mu/l

1.63

1132

4747

(3003434) Protein [Mass/volume] in Pleural fluid

640

2002

2.70

111.73

1.5

1.4

30.3

33.4

g/l

6.96

559

1799

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

221

323

5.74

111.47

2.8

2.3

60.2

54.0

umol/l

1.42

168

254

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

360

794

3.82

111.36

1.5

1.2

—

(3000330) Specific gravity of Urine by Test strip

1778

8399

1.82

111.13

5.5

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4278

25228

1.49

109.88

1.3

1.2

11.6

12.7

u/ml

0.41

1492

9659

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

338

721

3.94

109.47

13.6

11.5

0.6

mmol/l

0.96

310

656

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

354

782

3.81

109.26

1.5

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

745

2555

2.47

107.93

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

943

15868

0.48

107.87

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1112

4540

2.09

106.56

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

381

907

3.54

105.59

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

381

907

3.54

105.59

1.6

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

381

907

3.54

105.59

1.6

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

652

2127

2.59

104.76

3.3

3.1

1.5

1.4

0.14

511

1642

(3023199) Leukocytes [#/volume] in Pleural fluid

578

1775

2.75

104.52

1.5

1.4

2939.1

2284.1

e6/l

0.33

420

1273

(3011648) Oxygen content in Venous blood

416

1061

3.30

103.72

2.5

2.6

10.5

11.3

2.75

416

1061

(3009542) Hematocrit [Volume Fraction] of Blood

20855

159537

1.39

103.42

31.2

12.7

38.1

39.7

109.41

14219

113907

(3042111) Morphology [Interpretation] in Bone marrow Narrative

641

2092

2.59

102.91

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

676

2270

2.52

102.36

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

485

1373

2.98

101.68

3.6

3.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

536

1621

2.79

99.75

1.5

1.4

74514.2

51235.5

e6/l

0.63

337

949

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

406

1047

3.27

99.47

1.7

2.4

19.1

18.5

nmol/l

0.53

374

1005

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

980

3916

2.13

99.24

1.3

1.2

27.4

38.7

u/ml

0.82

234

(4062490)

454

1271

3.01

97.05

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

743

2687

2.34

95.74

3.3

2.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1857

9273

1.72

95.44

1.4

1.3

245.5

243.3

u/ml

0.02

1719

8536

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

312

696

3.77

95.03

1.6

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1019

4206

2.06

94.71

1.6

3.7

6.9

iu/ml

0.36

255

898

(3035947) Staphylolysin Ab [Units/volume] in Serum

265

526

4.23

94.41

1.2

1.1

3.3

3.8

iu/ml

0.33

(3045788) Cell count panel - Pleural fluid

469

1363

2.90

93.88

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

622

2094

2.51

93.67

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

289

617

3.93

93.54

1.1

1.0

1.1

u/l

0.16

126

277

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

515

1580

2.75

93.30

2.8

3.3

6.3

9.5

nmol/l

0.43

493

1534

(3012441) Differential panel - Pleural fluid

505

1534

2.78

93.21

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

449

1279

2.96

93.13

1.3

6.6

6.8

g/l

0.61

323

892

(3028192) IgG subclass 2 [Mass/volume] in Serum

449

1280

2.96

93.00

1.3

2.7

3.0

g/l

2.73

324

894

(3024139) IgG subclass 3 [Mass/volume] in Serum

449

1280

2.96

93.00

1.3

0.4

g/l

3.92

325

894

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

214

361

4.97

92.68

2.9

29.1

28.2

umol/l

0.45

152

282

(3011288) Drugs identified in Urine by Screen method

893

3537

2.14

92.45

4.0

2.4

—

(3019225) pH of Specimen

2878

16176

1.54

91.40

5.8

3.6

—

(3014271) Vancomycin [Susceptibility]

317

735

3.62

91.37

3.4

2.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

500

1527

2.76

91.37

1.4

1.3

33.8

35.2

nmol/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

259

520

4.18

90.94

1.2

1.3

69.5

65.5

0.20

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

391

1042

3.16

90.84

1.2

140.0

175.7

titre

0.46

199

(4035726)

2478

13512

1.58

89.88

1.4

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

389

1042

3.14

89.62

1.2

67.1

108.6

titre

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

550

1787

2.60

89.09

1.3

305.3

298.4

pmol/l

0.11

421

1399

(3020682) Albumin/Creatinine [Ratio] in Urine

7823

52750

1.33

88.81

4.1

3.9

15.3

7.7

mg/mmol

17.69

5038

32811

(3011412) CD3 cells [#/volume] in Blood

386

1038

3.13

88.36

2.0

2.2

1.2

e9/l

0.61

238

610

(1001926) Buprenorphine [Presence] in Urine by Screen method

984

4116

2.03

88.15

3.6

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

326

794

3.45

87.35

2.0

1.8

—

(40768806) Pleura Pathology biopsy report

497

1555

2.69

86.73

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

756

2882

2.22

86.04

1.3

1.2

37.4

46.2

u/ml

0.74

254

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

891

3629

2.08

85.74

1.3

6.0

8.8

u/ml

0.74

119

574

(3016650) Hepatitis A virus Ab [Presence] in Serum

611

2127

2.43

85.67

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

880

3575

2.09

85.26

1.3

6.7

5.9

u/ml

0.08

372

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

433

1277

2.85

84.43

3.1

2.5

—

(3049717) Cytology report of Urine Cyto stain

1340

6303

1.81

84.36

2.5

2.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

280

630

3.73

84.30

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

630

3.73

84.30

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

169

253

5.59

83.27

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

532

1772

2.53

81.92

7.8

9.6

7.6

7.5

mmol/l

0.17

466

1423

(3022621) pH of Urine by Test strip

2056

10952

1.61

81.92

4.1

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

962

4110

1.99

81.18

1.4

1.3

11.3

10.0

u/l

1.72

777

3338

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

255

5.48

80.63

1.1

—

(3037121) Protein [Mass/volume] in Urine

1156

5273

1.86

80.25

3.1

0.4

0.3

g/l

1.58

554

2157

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

304

749

3.41

80.07

2.0

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

440

1348

2.75

79.95

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

751

2945

2.16

79.68

1.3

1.2

1.8

19.0

u/ml

1.80

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

601

2154

2.35

79.01

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

479

1543

2.62

78.96

1.2

55.8

64.2

u/l

1.68

348

993

(3039000) Anion gap in Blood

827

3380

2.07

78.82

6.8

6.2

11.3

11.2

mmol/l

0.45

770

3031

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

893

3755

2.02

78.78

1.3

1.1

—

(3018572) Chloride [Moles/volume] in Blood

827

3381

2.07

78.76

6.8

6.2

104.7

105.3

mmol/l

2.60

770

3032

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

358

987

3.05

78.62

1.4

13.7

12.1

umol/l

2.88

332

933

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

156

232

5.63

77.41

1.1

—

(3051651) Icteric interference index of Serum or Plasma

313

804

3.27

77.25

3.9

3.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

159

242

5.50

77.04

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1496

7455

1.71

77.00

1.1

126.3

254.7

titre

1.55

214

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

227

469

4.06

76.85

3.2

2.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21542

167761

1.34

76.66

5.2

4.4

6.1

5.9

mmol/l

48.79

19507

152138

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

262

602

3.65

76.59

1.7

1.3

—

(3022145) Colonoscopy Study observation

3075

18165

1.46

75.76

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

262

607

3.62

75.68

1.7

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

259

597

3.64

75.37

1.6

6.8

7.0

nmol/l

0.02

202

508

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

740

2956

2.12

74.88

1.3

1.2

5.4

5.2

u/ml

0.02

231

(21494890) Protein electrophoresis panel - 24 hour Urine

450

1443

2.63

74.86

1.7

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

483

1611

2.53

74.18

3.9

3.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

158

248

5.33

74.13

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

264

625

3.54

73.88

2.7

2.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

320

860

3.13

73.39

1.2

99.4

82.0

u/l

2.29

280

746

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

214

438

4.10

73.37

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

514

1775

2.44

73.35

1.6

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

216

447

4.05

72.99

1.1

251.6

643.7

ng/l

0.56

111

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

315

842

3.14

72.90

1.2

28.2

20.7

u/l

2.26

270

713

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1330

6521

1.74

72.48

1.1

2.6

10.0

u/ml

0.78

(3036782) Glucose [Moles/volume] in Pleural fluid

429

1372

2.63

71.76

1.3

1.4

6.6

6.2

mmol/l

1.44

395

1267

(3012516) Albumin [Mass/volume] in Urine

7328

50122

1.30

71.52

3.3

3.2

561.5

359.0

mg/l

2.62

4884

31113

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

530

1878

2.38

71.49

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

289

742

3.27

71.41

2.6

1.9

95.0

98.1

0.73

274

681

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

296

4.81

71.11

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

500

1730

2.43

71.06

1.6

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

156

252

5.18

70.98

1.1

1.2

0.6

0.9

umol/24h

0.49

123

(3005988) Vibrio sp identified in Specimen by Organism specific culture

498

1722

2.44

70.88

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

496

1721

2.43

70.07

1.6

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1200

5770

1.77

69.96

1.7

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1534

7902

1.65

69.54

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

299

797

3.15

69.53

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

494

1717

2.42

69.53

1.6

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

305

826

3.10

69.09

2.0

1.9

75.0

71.2

3.90

290

797

(40768804) Tissue Pathology biopsy report

9710

69073

1.27

68.59

2.3

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

924

4129

1.90

68.25

1.5

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

212

455

3.91

68.25

30.5

26.3

113.5

118.7

ug/l

0.41

173

387

(3024522) Salmonella sp identified in Specimen by Organism specific culture

495

1737

2.40

68.23

1.6

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

963

4381

1.86

67.29

7.3

3.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2227

12621

1.51

66.93

3.8

2.5

59.7

66.2

ml/min/173m2

10.34

966

4854

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

240

571

3.52

66.72

1.5

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

240

571

3.52

66.72

1.6

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

297

809

3.08

66.64

2.0

1.9

12.0

14.5

1.69

157

382

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

746

3142

2.01

65.47

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

123

171

6.02

65.34

1.9

2.0

16.6

16.1

umol/l

0.14

123

171

(3016879) Cocaine [Presence] in Urine

1070

5076

1.79

65.25

3.6

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

326

951

2.88

64.92

2.0

42.8

43.1

0.03

142

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1060

14797

0.58

63.61

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

673

2761

2.06

63.47

1.6

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

280

763

3.08

62.81

1.9

2.3

516.2

499.1

e6/l

0.16

223

642

(3014051) Protein [Presence] in Urine by Test strip

823

3641

1.91

62.64

2.9

2.0

—

(3045414) Leukocytes [Presence] in Urine

1400

7238

1.65

62.43

2.4

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

532

2008

2.23

62.03

1.3

1.2

3.6

4.0

u/ml

0.35

249

900

(3000764) Benzodiazepines [Presence] in Urine

1123

5495

1.73

61.50

3.5

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

520

1958

2.24

60.99

2.8

2.5

731.6

1063.3

u/ml

0.22

506

1858

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

269

735

3.07

60.09

2.0

2.4

0.2

e9/l

4.54

226

640

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

334

1036

2.71

59.38

1.4

13.9

12.5

u/l

2.41

318

1009

(3017817) Protein [Mass] in Urine collected for unspecified duration

380

1258

2.54

59.35

1.9

2.4

1.2

0.6

—

(3028300) Cannabinoids [Presence] in Urine

1124

5558

1.71

59.25

3.6

1.7

—

(3027008) Opiates [Presence] in Urine

1122

5546

1.72

59.23

3.3

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1016

2.72

58.99

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

847

3858

1.86

58.92

1.8

1.9

14.8

10.2

iu/l

0.15

287

1399

(40759836) Histone Ab [Presence] in Serum by Immunoblot

328

1012

2.72

58.91

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

402

1375

2.46

58.63

1.3

415.7

512.8

u/l

0.48

372

1310

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

147

268

4.59

58.34

1.9

2.0

34.2

24.9

u/l

0.47

134

240

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1018

2.71

58.25

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1024

2.70

58.11

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1021

2.70

57.93

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

534

2079

2.16

57.71

1.3

1.2

3.3

3.5

u/ml

0.10

197

716

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1023

2.69

57.71

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

479

1785

2.26

57.60

1.3

1.2

32.2

60.9

u/ml

2.24

124

(3023487) Leukocytes [#/volume] in Peritoneal fluid

196

458

3.58

56.04

2.5

1.7

602.0

3000.8

e6/l

0.75

136

307

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

266

756

2.95

55.56

1.2

—

(3033799) Differential panel - Peritoneal fluid

175

382

3.84

55.13

2.4

1.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

166

351

3.96

54.62

1.3

1.1

111.1

111.8

0.11

150

313

(3042631) Mycobacterium sp identified in Specimen

496

1918

2.18

54.54

2.5

2.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

179

401

3.74

54.39

2.4

1.5

14144.6

7609.6

e6/l

0.31

110

207

(3019977) pH of Arterial blood

270

786

2.88

54.05

2.7

2.5

7.4

0.99

301

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

174

384

3.79

54.00

1.3

1.2

0.3

g/l

2.26

132

304

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

354

1188

2.50

53.79

1.1

—

(3045142) Bone marrow Pathology biopsy report

370

1269

2.45

53.68

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

456

1721

2.23

53.23

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

412

1491

2.32

53.08

3.6

3.3

—

(1761868) Lipid panel - Serum or Plasma

6053

60285

0.79

52.88

3.3

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1110

5641

1.67

52.79

2.5

2.1

7133.6

5513.7

u/l

0.69

346

2296

(3017354) Segmented neutrophils/100 leukocytes in Blood

379

1325

2.40

52.76

3.3

3.0

61.2

57.2

2.19

238

842

(3022493) Free Hemoglobin [Mass/volume] in Plasma

217

564

3.22

52.71

6.0

3.1

1193.9

1782.0

mg/l

0.18

149

400

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

181

419

3.62

52.49

2.3

2.4

136.8

156.9

nmol/l

1.64

151

364

(3027944) Amphetamines [Presence] in Urine

1080

5479

1.67

51.69

3.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

157

335

3.92

51.06

1.2

11.5

16.9

0.43

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

327

1084

2.53

50.99

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

131

243

4.51

50.98

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

302

964

2.63

50.84

1.6

1.8

4.5

3.8

mg/l

1.51

281

911

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

264

786

2.82

50.77

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

158

342

3.87

50.40

4.4

5.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

223

609

3.07

49.95

3.4

3.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

186

454

3.43

49.88

39.8

33.9

7.1

7.2

ug/l

0.24

171

412

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

194

488

3.33

49.67

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

212

566

3.14

49.32

1.8

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

212

566

3.14

49.32

1.8

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

212

566

3.14

49.32

1.8

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

567

2404

1.99

48.87

1.4

1.3

37.0

31.6

u/l

0.60

489

2052

(3000492) Spirometry study

2489

15248

1.40

48.84

1.5

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

211

566

3.12

48.71

1.8

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

265

809

2.75

48.65

2.2

2.4

631.3

717.5

e6/l

1.03

328

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

362

1289

2.36

48.42

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

378

1374

2.31

48.25

2.3

2.5

—

(3007461) Platelets [#/volume] in Blood

24346

195678

1.36

48.14

41.5

17.1

247.8

250.7

e9/l

8.09

23833

189442

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

176

425

3.47

47.99

1.8

3.0

1.3

1.1

ug/l

0.77

166

407

(3013005) Retinol [Moles/volume] in Serum or Plasma

202

533

3.17

47.93

2.2

1.8

1.9

umol/l

0.24

184

496

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

281

893

2.64

47.75

1.6

1.5

5.1

5.9

u/l

0.36

155

402

(3030313) Adrenal Ab [Titer] in Serum

109

6.44

47.71

1.1

—

(3044927) Protein electrophoresis panel - Urine

383

1407

2.29

47.71

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

232

666

2.92

47.68

1.6

1.5

10.1

8.5

ug/l

0.30

211

608

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

289

935

2.59

47.40

1.0

740.1

712.4

ng/l

0.44

197

635

(3035941) MCH [Entitic mass]

24352

195799

1.36

47.37

41.3

17.0

30.3

0.26

24014

192375

(3024731) MCV [Entitic volume]

24352

195822

1.36

47.10

41.4

17.0

91.4

90.9

41.40

24018

192386

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

111

6.32

46.92

3.2

3.4

40.4

39.5

umol/l

0.11

(3026361) Erythrocytes [#/volume] in Blood

24352

195842

1.36

46.86

41.5

17.1

4.3

4.5

e12/l

307.65

23779

188914

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

685

9930

0.56

46.84

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

155

349

3.72

46.83

1.4

1.2

113.7

128.7

nmol/l

0.49

103

253

(3010813) Leukocytes [#/volume] in Blood

24355

195885

1.35

46.68

41.6

17.1

7.1

6.7

e9/l

36.06

23789

188953

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

288

939

2.57

46.51

1.0

40.6

44.6

ng/l

0.80

197

649

(4010399)

1993

11839

1.43

46.47

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

24353

195898

1.35

46.31

41.8

17.2

129.3

135.6

g/l

307.65

24019

192476

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

201

540

3.12

46.31

2.2

1.7

26.6

29.6

umol/l

3.92

193

516

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

285

931

2.57

45.85

1.0

312.8

350.7

ng/l

1.01

202

654

(4306422)

496

2052

2.03

45.80

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

175

438

3.34

45.20

1.9

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1495

8441

1.50

45.18

1.1

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

168

410

3.43

45.12

1.7

1.9

27.6

26.8

0.31

159

395

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

477

1957

2.05

45.06

1.2

1.1

118.3

117.6

0.17

429

1746

(3013139) Helicobacter pylori Ag [Presence] in Stool

1840

10833

1.45

44.98

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

306

1048

2.45

44.62

1.1

296.0

289.7

mg/l

0.51

278

920

(3010503) CD19 cells [#/volume] in Blood

221

647

2.86

43.90

2.3

2.4

0.2

0.4

e9/l

1.39

211

625

(3006245) CD3-CD19+ cells/100 cells in Blood

169

423

3.34

43.67

1.8

2.0

11.0

11.4

0.14

157

402

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

470

1941

2.04

43.62

1.1

1.6

1.5

g/l

3.87

431

1728

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

460

1892

2.04

43.17

1.8

1.9

26.0

24.9

ug/l

0.13

447

1850

(3044007) Cell count panel - Peritoneal fluid

157

378

3.48

43.06

2.5

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

127

264

4.02

42.86

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

134

5.49

42.78

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

127

265

4.01

42.64

1.4

1.3

87.2

27.1

g/l

0.60

217

(3003338) MCHC [Mass/volume]

18931

148247

1.21

42.64

37.6

14.9

330.8

332.4

g/l

93.98

18714

146981

(3023420) DNA double strand Ab [Units/volume] in Serum

382

1476

2.17

42.19

1.7

1.4

24.8

31.8

iu/ml

0.44

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

216

639

2.83

42.12

3.0

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

313

1113

2.36

42.06

1.2

1.3

12.7

13.5

u/l

0.28

278

1046

(3017704) Immunofixation for Urine

238

742

2.69

42.05

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

121

246

4.11

42.05

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

202

4.47

41.69

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

120

245

4.09

41.48

1.1

1.0

7.3

7.2

mg/g

0.06

112

234

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

168

433

3.25

41.47

1.9

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

168

433

3.25

41.47

1.9

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

867

4400

1.66

41.41

1.1

5.7

6.9

u/ml

0.35

544

(3045716) Anion gap in Serum or Plasma

205

595

2.89

41.39

2.6

2.5

8.9

9.3

mmol/l

0.77

159

419

(3020717) Zinc [Moles/volume] in Serum or Plasma

211

623

2.84

41.30

1.8

1.4

24.5

26.2

umol/l

0.31

203

588

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1907

11473

1.41

41.27

2.4

2.1

11.3

12.0

nmol/l

3.00

1653

10136

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

166

427

3.25

41.12

2.9

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

166

427

3.25

41.12

2.9

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1256

6976

1.52

40.97

1.5

1.3

25.9

27.7

iu/l

1.12

1077

6036

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

657

3097

1.79

40.90

2.3

1.7

0.9

0.8

nmol/l

1.40

527

2581

(3000060) B lymphocytes [#/volume] in Blood

134

300

3.74

40.88

1.7

2.0

451.5

1067.5

e6/l

0.57

169

(3017732) Neutrophils [#/volume] in Blood

1871

11242

1.42

40.77

3.4

2.7

4.2

4.1

e9/l

0.86

1380

8611

(3004451) EKG impression Narrative

221

675

2.74

40.63

1.4

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

361

3.45

40.51

2.0

1.6

14928.2

20917.8

u/ml

0.15

(4268621)

363

1398

2.18

40.44

2.4

2.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

257

850

2.53

40.38

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

273

930

2.46

40.32

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

139

5.23

40.22

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

312

1131

2.31

40.16

1.6

1.5

28.0

25.4

u/ml

0.34

236

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

255

3.97

40.12

1.1

—

(3021788) Differential panel - Synovial fluid

593

2728

1.83

40.01

1.6

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

805

4043

1.68

40.00

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

257

857

2.51

39.71

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

271

928

2.45

39.59

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

267

908

2.46

39.59

1.3

1.2

—

(3024932) HLA-DR beta [Type]

141

336

3.51

39.32

1.1

—

(3024471) HLA-A [Type]

142

340

3.49

39.31

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

515

2279

1.90

39.23

1.2

1.1

20.2

10.2

au/ml

0.76

137

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

267

914

2.45

39.04

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4229

28805

1.26

38.72

1.8

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

229

732

2.62

38.58

1.2

201.2

375.8

u/l

1.62

215

676

(3008116) Ketones [Moles/volume] in Urine by Test strip

123

272

3.78

38.21

1.5

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

646

3095

1.76

38.07

3.0

3.1

614.6

805.9

u/ml

0.26

579

2806

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

101

5.95

38.04

1.0

—

(3042517) Benzodiazepines panel - Urine

104

5.86

37.99

3.9

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

5.62

37.90

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

400

1647

2.04

37.49

1.5

1.7

4050.0

2682.0

titre

—

(3000475) Leukocytes [#/volume] in Synovial fluid

727

3619

1.69

37.36

1.7

1.6

16213.5

13646.2

e6/l

0.69

527

2599

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

190

563

2.82

37.01

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

107

5.70

36.94

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

492

2199

1.88

36.39

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

509

2303

1.86

36.24

1.6

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

278

3.64

35.64

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7650

55828

1.20

35.50

4.8

5.1

5.6

3.3

ug/l

1.83

6692

49764

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

170

485

2.93

35.47

1.3

1.4

16.2

15.4

pmol/l

0.31

145

398

(3000012) Reticulocyte production index

248

860

2.42

35.32

1.8

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

334

1315

2.13

35.26

1.3

1.4

nmol/l

0.04

299

1183

(3026692) Albumin [Mass/volume] in Peritoneal fluid

131

320

3.42

35.24

1.8

1.3

12.4

13.5

g/l

0.67

247

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

126

302

3.49

34.89

1.4

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

206

660

2.61

34.60

1.9

2.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

356

1447

2.06

34.59

1.2

1.1

93.8

95.1

0.36

332

1348

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

175

515

2.84

34.55

1.7

1.5

4750224.4

1889763.4

iu/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

466

2082

1.88

34.53

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

221

734

2.52

34.51

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

739

3776

1.65

34.40

2.1

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

192

597

2.69

34.20

2.8

2.5

42.5

40.8

0.44

210

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

141

4.80

34.10

1.8

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

302

1158

2.19

34.09

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

129

319

3.38

34.08

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

141

370

3.19

33.91

1.5

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

113

257

3.67

33.80

1.4

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

172

509

2.83

33.63

2.1

2.0

66.5

61.3

ug/l

0.38

166

496

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

193

608

2.66

33.53

1.7

1.9

156.1

139.5

1.74

181

564

(3028433) Virus identified in Specimen by Culture

145

390

3.11

33.50

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

206

677

2.55

32.90

3.5

3.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.84

32.74

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

136

357

3.19

32.71

1.6

1.3

—

(3036603) Volume of Urine

263

969

2.27

32.71

1.7

1.6

1796.8

1943.5

0.57

243

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

128

324

3.30

32.63

1.1

1.2

308.0

305.5

pmol/l

0.02

236

(3029634) Reagin Ab [Titer] in Serum by VDRL

439

1961

1.88

32.58

1.9

13.1

7.1

titre

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

267

992

2.26

32.56

2.0

1.5

56.5

71.2

umol/l

2.68

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

463

2105

1.85

32.52

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

418

1842

1.90

32.33

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

5.31

32.02

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

416

1838

1.90

31.93

1.1

—

(3006270) Folate [Moles/volume] in Blood

336

1383

2.04

31.61

1.2

336.4

353.4

nmol/l

0.72

248

1171

(37021550) Renin [Units/volume] in Plasma --upright

113

272

3.47

31.14

1.4

1.3

86.5

62.5

mu/l

0.49

204

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

384

1670

1.93

30.92

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

217

3.77

30.48

3.1

2.6

14.9

14.8

ml/dl

0.14

201

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

149

431

2.89

30.41

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

331

1381

2.01

30.03

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.48

29.71

2.1

1.8

—

(3035880) pH of Pleural fluid

225

809

2.33

29.66

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

142

4.47

29.49

1.7

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

139

394

2.95

29.43

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

189

630

2.51

29.38

2.2

—

(21494434) Karyotype in Bone marrow

296

1195

2.08

29.37

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

146

427

2.86

29.24

1.3

1.2

0.9

0.4

g/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

123

4.75

29.21

1.1

1.2

1.5

1.8

umol/24h

0.74

123

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

514

2.67

28.86

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

121

322

3.14

28.53

1.4

1.2

16.8

16.9

umol/l

0.08

112

284

(3004616) Nuclear Ab [Presence] in Serum

388

1741

1.87

28.46

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

185

620

2.50

28.45

1.6

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

337

1447

1.95

28.22

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

234

3.53

28.08

1.1

3.1

12.3

pmol/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

313

3.15

27.98

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

121

326

3.10

27.96

2.2

1.7

—

(40768446) Kidney Pathology biopsy report

160

505

2.65

27.79

1.9

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

106

264

3.35

27.79

1.4

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

256

1000

2.14

27.70

1.3

400.8

507.3

titre

0.18

(3035320) C reactive protein [Mass/volume] in Body fluid

282

1148

2.06

27.41

3.1

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

223

829

2.25

27.25

1.3

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

159

4.10

27.17

1.4

1.2

39.2

55.0

1.56

(3020876) Protein [Mass/time] in 24 hour Urine

310

1312

1.98

27.07

1.7

1.9

1.0

1.2

g/24h

0.20

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

248

966

2.15

27.04

1.3

47.7

59.0

titre

0.31

(3047007) Chlamydophila sp Ab [Presence] in Serum

441

2092

1.77

27.02

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

241

3.43

26.89

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

270

1090

2.07

26.84

2.3

1.6

—

(3008898) HLA-B27 [Presence]

880

4959

1.49

26.78

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

238

3.44

26.72

2.8

2.3

—

(3025315) Body weight

103

4.94

26.66

5.2

3.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

219

816

2.25

26.63

2.8

3.2

21.7

28.1

mu/l

1.58

198

769

(3028679) Herpes simplex virus Ab [Presence] in Serum

193

689

2.34

25.93

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

151

480

2.63

25.90

1.4

1.5

457.3

838.7

mu/l

0.93

144

458

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

153

490

2.61

25.86

1.4

1.5

74.2

72.0

1.21

146

468

(40768441) Liver Pathology biopsy report

252

1010

2.09

25.56

1.6

1.2

—

(3016228) CD19 cells/100 cells in Blood

139

428

2.71

25.38

2.3

1.9

7.8

9.4

0.71

133

414

(3032057) Clostridioides difficile [Presence] in Stool

102

263

3.24

25.37

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

153

4.04

25.33

2.2

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

131

394

2.78

25.00

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

182

648

2.35

24.63

1.2

1.1

3.9

13.9

u/ml

1.15

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

179

3.73

24.61

5.6

5.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

201

748

2.25

24.56

2.0

2.2

29.0

36.3

umol/l

0.27

(3014891) Appearance of Pleural fluid

200

3.55

24.33

1.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

188

683

2.30

24.31

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

134

415

2.70

24.22

2.3

1.9

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

106

4.65

24.05

1.3

1.4

13.9

13.6

pmol/l

0.03

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

203

3.50

23.81

1.2

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

544

2830

1.61

23.69

2.1

1.8

193.9

192.7

pmol/l

0.09

507

2670

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

157

534

2.46

23.50

3.2

2.2

—

(3005570) Glucose [Moles/volume] in Urine

359

1673

1.80

23.42

2.0

1.8

—

0.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

198

3.50

23.30

1.2

1.4

1019.6

161.7

ng/l

0.42

125

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

310

1383

1.88

23.25

1.7

1.5

24.1

31.5

3.37

198

827

(3051593) INR in Capillary blood by Coagulation assay

203

778

2.18

23.13

6.8

11.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

247

1022

2.02

23.06

1.3

0.7

1.2

u/ml

0.69

116

457

(40768443) Skin Pathology biopsy report

1191

7294

1.38

23.01

1.2

—

(3012565) Volume of 24 hour Urine

197

748

2.20

22.97

1.9

2.2

1930.1

1927.2

0.01

166

654

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

441

2203

1.68

22.53

1.5

1.4

0.3

0.5

nmol/l

7.53

330

1736

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

137

454

2.52

21.70

1.8

1.9

191.7

162.0

1.61

131

420

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

137

456

2.51

21.51

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

121

380

2.66

21.35

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

736

4196

1.47

21.20

1.9

1.6

42.7

43.1

nmol/l

0.15

724

4064

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

179

3.50

21.08

2.2

1.9

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

173

3.52

20.74

1.4

1.6

126.9

110.5

ug/l

0.47

139

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

106

4.33

20.65

6.1

7.5

—

(40757373) Influenza virus identified in Isolate

250

3.04

20.49

1.7

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

191

3.37

20.44

1.4

8.3

246161.5

nmol/l

1.73

156

(3034426) Prothrombin time (PT)

131

440

2.49

20.22

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2372

16220

1.24

20.03

2.2

2.0

—

(4212803)

127

3.94

19.99

1.1

1.0

—

(3002619) Bacteria identified in Specimen by Culture

103

310

2.78

19.75

1.5

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

680

8124

0.69

19.52

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.05

19.33

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

273

2.88

19.24

1.6

2.0

1.2

mmol/l

0.60

261

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

130

446

2.44

19.21

1.1

106.4

109.0

0.32

123

394

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

413

2117

1.64

19.18

1.4

1.3

25.3

26.6

u/l

0.33

352

1728

(40768795) Lymph node Pathology biopsy report

246

1086

1.90

19.16

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.08

18.99

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.18

18.95

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

198

814

2.03

18.92

2.3

2.1

84.2

84.8

ug/min

0.01

183

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.35

18.89

1.3

1.1

58.0

45.0

mg/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

643

3655

1.48

18.85

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

199

821

2.03

18.84

1.6

1.2

4.3

5.0

umol/l

1.69

185

759

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

18.70

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.17

18.69

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

126

432

2.44

18.66

1.1

88.5

90.4

0.20

185

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

5.47

18.57

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

523

2863

1.53

18.38

1.9

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

151

3.54

18.35

1.3

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

245

1099

1.87

18.20

1.3

1.2

23.6

45.6

u/ml

1.45

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

127

443

2.40

18.13

1.1

90.5

90.3

0.02

182

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

244

1096

1.86

18.05

1.3

1.2

54.6

71.3

u/ml

0.49

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

118

3.89

18.03

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

100

4.17

17.97

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

3.72

17.91

1.8

46.3

40.7

umol/l

0.60

130

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

841

1.98

17.66

1.6

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

455

2.35

17.55

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

248

1132

1.83

17.46

1.3

1.2

46.0

41.8

u/ml

0.09

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.67

17.32

1.1

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

204

3.07

17.24

2.4

2.5

64.2

49.0

mg/l

0.26

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

111

3.91

17.18

8.2

7.3

0.4

0.3

umol/l

0.08

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.54

17.16

1.5

1.6

1.9

mg/l

0.03

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

458

2476

1.55

17.07

3.9

3.2

86.7

35.3

u/ml

2.17

440

2384

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

412

2175

1.59

17.02

1.1

3.0

3.6

u/ml

0.34

131

1044

(3006576) Bicarbonate [Moles/volume] in Blood

142

535

2.22

17.02

5.1

6.0

24.6

25.0

mmol/l

0.47

132

486

(3014148) Varicella zoster virus Ab [Titer] in Serum

352

1793

1.64

16.83

1.1

—

(3024263) Appearance of Synovial fluid

191

810

1.97

16.81

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.26

16.73

1.4

1.5

401.0

625.4

nmol/l

0.93

(3011544) Albumin [Mass/volume] in Pleural fluid

133

3.58

16.65

1.2

1.1

15.7

18.6

g/l

1.77

123

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

183

768

1.99

16.59

1.1

31.6

21.9

u/l

1.48

145

586

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

129

473

2.28

16.51

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

130

3.59

16.48

1.1

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.23

16.44

1.1

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

163

3.28

16.39

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

182

768

1.98

16.26

1.1

92.9

83.5

u/l

0.65

150

607

(3038177) Helicobacter pylori Ab [Presence] in Serum

468

2571

1.53

16.24

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

4.17

16.20

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1287

8393

1.29

16.17

3.8

3.2

89.1

50.4

u/ml

2.24

1232

8105

(3010144) Erythrocytes [#/volume] in Synovial fluid

286

1394

1.72

16.16

1.4

189970.0

118007.6

e6/l

0.81

200

943

(3001686) Cold agglutinin [Titer] in Serum or Plasma

217

2.92

16.11

1.2

1.3

80.0

245.1

titre

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2568

18090

1.20

16.01

2.3

2.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

174

3.17

16.01

2.2

2.0

1.2

1.8

mmol/l

1.07

128

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

103

346

2.49

16.00

2.3

2.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

192

831

1.93

15.96

1.1

ratio

0.00

295

(3008536) Aspergillus sp Ab [Presence] in Serum

205

2.97

15.93

2.0

1.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

141

545

2.16

15.91

1.4

64.6

64.5

0.01

109

460

(3050129) First trimester maternal screen panel - Serum or Plasma

428

5369

0.66

15.90

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

175

3.15

15.86

1.7

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.62

15.85

1.1

1.0

—

mmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

156

629

2.07

15.80

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

138

3.45

15.79

2.0

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.12

15.63

1.3

1.1

—

(3007463) Buprenorphine [Presence] in Urine

6.78

15.58

9.8

5.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

213

2.90

15.48

1.7

1.9

111.9

43.6

pmol/l

0.58

178

(3010838) Calcium [Moles/time] in 24 hour Urine

176

748

1.97

15.44

1.6

6.1

5.8

mmol/24h

0.07

(3003694) ABO and Rh group [Type] in Blood

6394

48399

1.13

15.44

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

449

2473

1.52

15.42

1.1

67.0

5257.5

iu/ml

0.65

524

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

153

3.27

15.36

1.1

0.0

0.3

u/ml

0.79

102

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

119

436

2.28

15.30

1.2

1.3

585.7

183.1

ug/l

0.70

245

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

304

1530

1.66

15.28

1.1

3.1

1.8

iu/ml

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

361

2.41

15.10

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

3.51

15.10

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

131

3.44

14.93

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

4.12

14.92

1.3

1.1

22.5

23.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

224

1046

1.79

14.73

1.3

1.2

1.8

11.1

u/ml

2.18

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

363

4632

0.65

14.67

1.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

1.2

0.9

mg/l

0.19

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

1.3

1.8

mg/l

0.32

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

1.1

1.9

mg/l

0.90

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

0.4

0.8

mg/l

0.95

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

2.5

4.1

mg/l

0.97

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

1.7

2.1

mg/l

0.15

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

1.4

1.8

mg/l

0.18

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

2.0

3.0

mg/l

0.47

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.22

14.66

1.5

1.6

2.5

2.9

mg/l

0.14

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

306

2.51

14.64

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

221

2.79

14.52

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

283

1419

1.67

14.46

2.2

2.0

2.5

2.6

u/field

0.08

128

565

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

110

3.64

14.43

3.3

3.2

1.5

1.3

mg/l

0.21

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.17

14.43

1.4

1.3

46.2

34.8

0.72

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

122

467

2.18

14.16

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

8.34

14.13

2.0

1.5

174.5

262.2

nmol/l

0.61

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

204

939

1.82

14.09

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.56

14.09

3.3

3.1

2.4

2.5

mg/l

0.05

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

356

1902

1.57

14.07

1.7

1.5

64.9

56.7

3.55

225

1161

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.35

14.06

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

182

810

1.88

13.99

1.6

1.5

1.3

1.2

nmol/l

0.61

134

639

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.23

13.95

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

123

476

2.16

13.91

1.3

4.0

3.6

mmol/l

0.38

110

443

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

4.75

13.91

1.1

1.0

2.4

u/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

269

3614

0.62

13.74

1.5

—

(3005033) Fetal Nuchal fold Thickness US

260

3520

0.61

13.72

1.4

—

(3002256) Pathology report gross observation

3090

22397

1.17

13.72

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

3528

0.61

13.69

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

12.51

13.68

1.0

—

(3036180) Methadone [Presence] in Urine

12.51

13.68

4.1

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.63

13.64

2.3

2.5

—

(3017509) Phencyclidine [Presence] in Urine

131

3.31

13.61

2.7

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

676

4119

1.38

13.60

2.3

146.1

97.4

ug/min

1.44

346

2445

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1219

8080

1.27

13.48

1.9

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

184

2.90

13.48

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.17

13.37

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

344

4336

0.66

13.16

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

105

390

2.25

13.15

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

343

4325

0.66

13.14

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

344

4334

0.66

13.13

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

343

4308

0.66

12.90

1.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.11

12.79

1.1

1.2

1.4

1.0

u/field

1.75

(3033942) Copper [Moles/time] in 24 hour Urine

4.94

12.78

1.0

1.2

0.4

0.6

umol/24h

0.31

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.30

12.76

1.4

1.2

2.0

0.9

0.50

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.01

12.72

1.3

1.5

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.34

12.71

1.2

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

120

479

2.09

12.59

1.4

2.8

0.03

412

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.73

12.52

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.12

12.38

2.9

2.6

—

(3045424) Erythrocytes [Presence] in Urine

466

2709

1.44

12.33

1.6

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

195

926

1.76

12.22

1.8

2.2

2.7

u/field

0.25

145

638

(3018133) Calcium [Moles/volume] in Urine

220

2.62

12.04

2.1

2.5

2.9

2.7

mmol/l

0.41

202

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1496

10279

1.23

12.01

2.0

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5844

44558

1.12

11.99

4.2

4.4

22.2

0.03

2705

22457

(4024509)

299

1596

1.57

11.95

1.7

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.76

11.72

1.3

1.5

16.7

17.6

pmol/l

0.09

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.99

11.66

1.2

1.1

38.5

53.9

u/l

1.12

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.89

11.60

1.4

1.3

12.8

11.1

0.22

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

196

2.68

11.54

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

137

3.04

11.49

1.2

95.8

107.6

ug/l

0.26

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

301

2.33

11.49

1.3

1.1

89.3

83.8

0.34

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

343

2.24

11.48

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

343

2.24

11.48

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

343

2.24

11.48

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

343

2.24

11.48

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

349

2.22

11.43

4.3

6.8

67.2

72.2

0.89

283

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

302

2.32

11.41

1.2

1.1

69.8

70.1

0.01

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

373

2111

1.48

11.38

2.4

2.0

26.6

29.2

mg/l

0.33

574

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.04

11.36

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.17

11.24

2.6

1.5

211.6

195.4

ug/g

0.16

(1002224) Polysomnography panel

949

6244

1.28

11.21

1.1

—

(44806420)

118

490

2.01

11.20

2.2

2.4

—

(4034850)

834

5398

1.30

11.20

13.3

9.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2917

21378

1.15

11.08

12.7

6.1

—

(3000285) Sodium [Moles/volume] in Blood

191

2.66

11.06

1.5

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.83

11.05

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

107

431

2.07

11.03

1.4

67.8

54.3

3.50

368

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

117

3.14

10.65

1.1

—

(3020491) Glucose [Moles/volume] in Blood

233

1208

1.61

10.59

2.0

1.8

7.5

6.7

mmol/l

2.42

170

850

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

302

2.27

10.57

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

344

1946

1.48

10.56

2.1

8.4

6.9

umol/l

0.67

248

1419

(3007916) DNA double strand Ab [Titer] in Serum

158

2.80

10.55

1.3

1.4

278.0

232.9

titre

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

185

906

1.71

10.48

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

189

2.60

10.26

5.1

4.9

40.6

41.5

ug/min

0.03

150

(3034891) Synovial lining cells/100 cells in Synovial fluid

154

722

1.78

10.17

1.7

1.4

3.6

4.2

0.19

150

(3043410) Blood group antigens tested for on Red Blood Cells

104

428

2.03

10.16

1.9

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

112

3.13

10.14

1.4

1.2

16.2

14.2

nmol/l

0.24

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.30

9.99

1.4

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

104

434

2.00

9.80

1.4

20.1

19.8

0.04

398

(3011335) Digoxin [Mass/volume] in Serum or Plasma

119

3.01

9.78

2.6

2.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

175

2.62

9.72

1.4

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.28

9.66

2.2

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

589

1.84

9.62

1.1

1709.2

1487.8

miu/ml

1.12

130

589

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

139

1994

0.58

9.42

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.21

9.37

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

111

3.01

9.08

3.1

2.2

55.8

61.8

0.36

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

228

2.34

8.97

1.5

1.4

7.5

10.9

0.81

119

(3004775) Volume in Urine collected for unspecified duration

253

1396

1.51

8.85

2.1

2.2

719.9

646.9

1.06

143

956

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

130

607

1.79

8.78

2.5

2.0

22.1

245.1

ug/l

1.85

121

566

(4015189)

406

1.97

8.77

2.1

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

260

1446

1.50

8.77

3.7

4.9

188.3

115.3

u/ml

0.49

444

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

312

1805

1.45

8.63

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

342

2.05

8.53

1.5

0.3

0.4

ug/l

0.86

205

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

130

614

1.77

8.46

1.0

1.1

99.3

95.5

0.57

105

469

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.17

8.39

1.1

1.0

128.9

220.7

pmol/l

0.69

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.17

8.38

2.3

2.5

—

(3000034) Microalbumin [Mass/volume] in Urine

262

1479

1.48

8.25

3.4

3.0

40.2

52.0

mg/l

0.50

194

1060

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

2.66

8.25

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

7.22

8.19

1.4

1.0

143.7

138.9

mmol/24h

0.11

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

399

1.95

8.19

1.6

—

604.6

iu/ml

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.80

8.17

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.17

8.03

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

289

2.11

8.00

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.23

7.95

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

107

2.88

7.87

1.5

1.4

1.1

1.8

ml/s/173m2

0.47

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

185

2.39

7.82

1.2

1.3

90.6

243.1

u/l

0.46

139

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.84

7.82

2.3

2.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

323

2.02

7.62

2.2

2.5

7.1

7.6

mmol/l

0.69

178

(3039443) Prostate specific Ag panel - Serum or Plasma

226

2758

0.68

7.55

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

242

2914

0.69

7.52

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4182

32052

1.10

7.38

2.9

3.1

0.8

ug/l

0.49

2879

21646

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

102

2.86

7.36

2.7

3.1

28.6

35.0

pmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.17

7.31

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2100

15482

1.14

7.29

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.82

7.20

1.1

1.2

1.3

1.0

u/field

0.43

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.57

7.17

5.2

4.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.94

7.11

1.7

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

215

2.21

7.09

1.2

1.3

1.2

1.5

mmol/l

0.12

140

(3036670) Protein [Mass/volume] in Synovial fluid

100

463

1.80

7.04

1.2

38.7

39.6

g/l

0.30

243

(3046861) Legionella sp Ag [Presence] in Urine

3.34

7.03

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

5.56

7.00

1.1

1.4

83.2

18.6

e6/l

—

(40759632) Porphyrins [Mass/mass] in Stool

8.34

6.98

1.0

1.2

—

(4094501)

651

4349

1.25

6.93

1.1

—

(44813793)

206

1151

1.50

6.91

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1140

0.53

6.83

1.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.29

6.82

5.8

6.5

0.8

1.1

mg/l

0.78

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

768

0.43

6.82

1.1

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

312

3526

0.73

6.68

1.7

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.60

6.65

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

153

2.40

6.61

1.3

1.1

21.7

18.5

u/l

0.38

(37019676) Renin [Units/volume] in Plasma --supine

4.60

6.58

1.1

1.0

88.0

71.0

mu/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.60

6.58

1.9

2.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.53

6.47

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

249

1466

1.42

6.40

1.3

11.4

12.0

mmol/l

0.48

103

328

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

357

1.87

6.37

1.4

21.3

21.5

0.01

310

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

6.55

6.37

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

180

997

1.51

6.34

1.1

7.5

8.5

iu/ml

0.22

248

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.84

6.28

3.2

2.2

9.8

19.7

1.08

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

103

2.67

6.18

1.0

1.1

6.2

11.1

u/l

1.09

103

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

347

3813

0.76

6.17

1.6

1.5

—

(3022475) Manganese [Moles/volume] in Blood

2.81

6.16

1.1

1.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.40

6.14

1.0

0.2

0.1

u/ml

0.51

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.50

6.12

1.1

1.2

215.2

278.3

nmol/l

0.85

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

104

509

1.71

6.12

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

230

2.07

6.05

2.9

2.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

114

2.56

6.04

7.7

4.7

—

(3032641) Amino acids panel - Urine

6.11

6.00

1.4

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

221

2.08

5.92

1.5

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.67

5.86

1.4

0.8

0.7

u/field

—

(3003129) Base excess in Capillary blood by calculation

393

1.78

5.80

1.6

1.8

0.8

0.4

mmol/l

0.30

371

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

581

1.64

5.78

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

6.41

5.68

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

108

2.55

5.66

1.0

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

5.73

5.66

1.0

0.2

0.4

u/ml

—

(3018291) Platelet Ab [Presence] in Serum

5.73

5.66

1.2

1.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.49

5.61

1.4

1.5

176.0

122.9

nmol/l

—

(3012898) Urea [Moles/volume] in Urine

139

2.34

5.60

1.3

1.5

193.8

155.4

mmol/l

0.97

123

(44786800) Granulocytes/100 leukocytes in Body fluid

199

2.10

5.54

1.3

21.5

25.5

0.38

156

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

233

2.00

5.52

3.5

4.6

141.1

41.6

u/l

0.89

104

(3039744) RNA polymerase III Ab [Units/volume] in Serum

115

2.47

5.47

1.1

1.0

6.9

2.7

u/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

217

2.04

5.46

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.92

5.45

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

214

2.03

5.29

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

117

2.42

5.29

1.0

0.1

0.4

u/ml

0.62

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.49

5.25

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

425

2799

1.27

5.23

1.1

4.0

5.5

u/ml

1.99

238

1469

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

221

2.00

5.21

1.3

1.6

5.0

5.1

nmol/l

0.06

213

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

123

2.37

5.21

1.1

1.0

0.3

0.4

u/ml

0.09

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

145

2.24

5.12

1.4

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

125

2.33

5.04

1.1

1.0

1.3

3.2

u/ml

0.28

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.65

5.03

1.0

4.6

0.3

u/ml

0.46

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

230

1.96

5.02

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.96

4.99

1.0

—

(3016750) Collection duration of Urine

173

1002

1.44

4.98

2.1

519.2

499.3

min

1.64

113

756

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

357

1.75

4.95

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

468

3140

1.25

4.94

1.2

1.1

2.9

1.8

u/ml

0.78

205

1299

(4281824)

286

1804

1.32

4.91

1.3

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

215

1.98

4.89

1.1

1.0

96.2

78.9

ug/l

1.85

171

(3005011) Chlamydia sp Ab [Titer] in Serum

221

1.96

4.88

1.6

1.7

—

(3001729) Color of Synovial fluid

122

2.32

4.86

1.7

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.64

4.83

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

159

912

1.46

4.83

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19962

163527

1.07

4.81

4.2

3.8

1.3

mmol/l

34.83

18040

148874

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.97

4.79

1.0

1.2

2990.9

2510.7

ng/l

0.13

(3024316) Viscosity of Plasma

3.11

4.67

1.6

1.8

1.7

2.0

mpas

0.69

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

774

5490

1.18

4.63

2.2

1.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.58

4.63

1.1

1.0

8.1

9.9

u/ml

0.18

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.19

4.62

1.8

1.3

65.6

114.8

ug/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21251

174516

1.07

4.58

5.2

4.8

2.6

2.8

mmol/l

174.12

19330

160067

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

131

2.23

4.56

1.0

0.3

0.1

u/ml

0.37

(40758292) HTLV I+II Ab panel - Serum

188

2.00

4.46

1.4

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.90

4.40

7.9

2.4

—

(3049233) Organic acids panel - Urine

4.90

4.40

1.2

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.90

4.40

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.90

4.40

3.0

4.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

260

1.83

4.37

1.1

1.3

0.0

5.2

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

310

2020

1.28

4.25

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate

134

765

1.46

4.23

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

499

5013

0.83

4.22

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

109

2.29

4.21

2.4

2.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

294

1.76

4.21

1.1

1.2

1.5

1.7

mmol/l

0.63

179

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

204

1.92

4.20

2.5

2.6

55.7

71.4

pmol/l

0.53

184

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

149

869

1.43

4.20

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

217

1.88

4.14

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

217

1.88

4.14

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

217

1.88

4.14

1.2

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

11.67

4.10

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

162

964

1.40

4.10

1.1

0.4

2.3

u/ml

2.99

299

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

260

1.80

4.09

1.1

6.8

11.2

u/ml

0.30

196

(3013293) Extractable nuclear Ab [Presence] in Serum

225

1.85

4.03

1.6

—

(3048879) Bone marrow aspiration report

414

1.61

3.96

1.8

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

408

1.62

3.94

1.5

1.6

9.6

8.7

ug/l

1.16

408

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

338

1.68

3.93

2.5

2.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.21

3.90

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.95

3.88

1.1

0.1

0.0

u/ml

0.21

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.61

3.87

1.1

1.2

0.1

g/l

1.74

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.55

3.86

1.0

0.1

0.3

u/ml

0.64

(3001019) Free T4 and TSH panel - Serum or Plasma

866

8252

0.87

3.86

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

119

2.17

3.86

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

464

1.56

3.82

2.8

2.9

121.8

147.8

au/ml

0.21

(3008401) Mugwort IgE Ab [Units/volume] in Serum

395

2688

1.23

3.77

1.1

1.4

1.1

u/ml

0.26

184

1185

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.68

3.69

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

496

1.53

3.64

3.2

3.6

7.9

7.8

mg/l

0.08

390

(3010726) Horse dander IgE Ab [Units/volume] in Serum

383

2611

1.23

3.61

1.1

2.2

u/ml

2.53

112

681

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.90

3.56

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

454

1.54

3.51

1.1

10.5

16.9

u/ml

0.21

265

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.21

3.41

1.0

1.1

4.9

0.7

u/ml

0.48

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

190

1.84

3.39

1.4

72.2

71.9

0.02

164

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.55

3.38

1.5

0.0

0.3

u/l

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

10.00

3.36

1.0

1.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

10.00

3.36

1.2

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.33

3.32

8.7

7.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

122

2.05

3.28

1.0

1.1

11.3

13.5

iu/ml

0.14

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

385

1.56

3.19

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.17

3.16

1.2

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

124

2.02

3.15

1.1

1.3

—

(40768800) Prostate Pathology biopsy report

353

3552

0.83

3.15

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.40

3.13

1.0

—

(44806071)

184

1.81

3.09

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

209

1.76

3.07

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

103

2.10

3.05

1.9

0.6

0.00

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

263

1758

1.25

3.04

1.1

1.0

0.2

0.4

u/ml

0.53

416

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.35

3.02

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

303

2063

1.23

2.97

1.1

4.8

4.9

u/ml

0.03

138

880

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

657

4782

1.15

2.96

1.2

1.3

195.9

229.1

miu/ml

1.42

247

2283

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

4.17

2.84

1.3

27.3

26.2

mg/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.33

2.83

1.6

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

235

1.67

2.77

2.3

2.8

1254.7

2121.9

u/l

0.44

217

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.19

2.73

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

462

1.46

2.71

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

156

1.82

2.69

1.0

1.1

1.0

7.2

u/ml

1.24

121

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.86

2.64

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.21

2.63

1.3

2.4

2.1

1.9

mu/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

529

3829

1.15

2.63

5.1

3.0

28.1

27.6

mg/l

0.13

359

2445

(3009677) Dengue virus Ab [Presence] in Serum

2.71

2.61

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.71

2.61

1.1

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.75

2.60

1.1

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.02

2.58

1.0

1.4

0.1

8.3

u/ml

0.80

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.78

2.52

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

381

1.49

2.51

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.56

2.49

1.5

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.17

2.45

1.4

1.3

1.0

1.2

u/field

1.08

(3042628) Porphyrins [Moles/volume] in Urine

6.94

2.43

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.21

2.41

4.1

3.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

510

3713

1.15

2.37

1.4

190.2

138.0

pmol/l

0.82

489

3619

(3006462) Nitrate [Presence] in Urine

132

839

1.31

2.36

3.5

3.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.08

2.35

1.1

1.2

18.6

25.3

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.08

2.35

1.1

1.2

40.6

35.0

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

315

2211

1.19

2.34

1.1

3.0

4.3

u/ml

1.20

138

909

(3007147) Virus identified in Stool by Electron microscopy

5.00

2.33

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

307

1.52

2.32

1.3

1.2

66.8

21.7

mg/l

0.45

234

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.17

2.32

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

158

1.74

2.31

1.0

1.1

0.2

3.9

u/ml

3.15

125

(3014599) Egg white IgE Ab [Units/volume] in Serum

146

945

1.29

2.30

1.0

1.1

0.5

5.2

u/ml

1.16

258

(3021691) Plasmodium malariae Ab [Titer] in Serum

5.95

2.23

2.6

3.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.89

2.19

1.1

—

(3001556) Androgen free Index in Serum or Plasma

130

1.80

2.18

1.8

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.15

2.16

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.19

2.12

8.6

7.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.11

2.09

1.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.91

2.08

6.2

2.7

11.8

10.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

5.21

2.06

1.4

1.6

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

5.21

2.06

1.4

1.6

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.21

2.06

1.0

15.2

16.0

umol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3111

27155

0.95

2.04

1.5

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.17

2.03

1.3

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

380

1.43

2.00

10.7

7.2

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.69

2.00

2.5

1.3

0.9

0.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

464

1.38

2.00

2.0

7.8

9.5

mg/l

2.13

382

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

119

766

1.30

2.00

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

244

1.54

2.00

1.7

1.5

0.2

nmol/l

0.28

173

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

231

1.55

1.99

3.1

2.5

0.5

0.6

u/field

0.21

231

(3019174) dRVVT (LA screen)

123

1.76

1.94

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.85

1.92

1.0

0.4

1.0

u/ml

1.14

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

329

0.58

1.85

1.1

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.90

1.85

1.3

1.1

80.6

89.9

nmol/24h

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

261

1848

1.18

1.83

1.4

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.53

1.80

1.4

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

114

1.75

1.78

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

4.17

1.77

1.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.17

1.77

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.07

1.77

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

208

1.52

1.67

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

188

1.55

1.67

2.1

2.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2496

21780

0.95

1.65

4.6

4.5

32.6

32.7

0.04

1826

14484

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.79

1.65

1.0

1.2

—

(4211845)

137

925

1.24

1.62

3.5

3.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

118

1224

0.80

1.60

1.4

1.6

7.9

7.7

mmol/l

0.32

734

(3020650) Glucose [Presence] in Urine

420

1.35

1.59

1.6

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

282

0.59

1.56

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

282

0.59

1.56

6.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

319

2330

1.14

1.54

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

114

1.68

1.51

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.04

1.51

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

318

2328

1.14

1.50

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.74

1.47

1.4

1.8

0.6

0.7

umol/l

0.49

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.25

1.45

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

334

1.37

1.45

11.4

7.2

—

(36303858) Crystals [Presence] in Urine

2.54

1.44

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

763

5867

1.09

1.44

1.8

1.6

3.8

3.3

mg/l

0.71

570

4006

(3016273) Islet cell 512 Ab [Units/volume] in Serum

105

1.67

1.36

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.63

1.35

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1741

15240

0.95

1.35

1.5

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.98

1.34

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.14

1.32

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

277

1.38

1.30

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.38

1.29

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

357

1.33

1.27

5.5

6.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.73

1.26

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.78

1.26

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.82

1.22

1.0

0.1

0.8

u/ml

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

375

1.31

1.20

1.6

1.7

47.2

102.5

au/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

156

1.50

1.20

1.1

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.84

1.17

27.9

9.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

137

964

1.19

1.15

5.8

6.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

131

1.53

1.13

4.8

2.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

105

725

1.21

1.10

5.5

5.0

444.8

6054.1

u/ml

0.53

118

(3009015) Lactate [Moles/volume] in Synovial fluid

153

1.47

1.09

1.2

5.5

6.0

mmol/l

0.27

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

331

1.31

1.08

1.4

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.16

1.06

1.4

—

(46236302) HLA-C [Type] by High resolution typing

2.16

1.06

1.0

—

(40760410) HLA-B [Type] by High resolution

2.16

1.06

1.0

—

(40763590) HLA-DQ beta [Type]

2.16

1.06

1.0

—

(40760409) HLA-A [Type] by High resolution

2.16

1.06

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.82

1.06

2.3

3.5

—

0.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.31

1.03

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

626

5598

0.93

1.03

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.08

1.03

2.3

2.1

—

(3013862) HLA-DP [Type]

2.08

1.03

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.92

1.02

2.6

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

505

1.24

1.01

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

479

1.24

0.96

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

193

1.38

0.95

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

119

846

1.17

0.94

1.1

1.0

5.0

0.5

u/ml

0.44

131

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

121

0.55

0.94

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.56

0.90

1.1

1.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.96

0.90

1.0

—

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20658

171180

1.02

0.90

4.7

4.3

4.4

4.7

mmol/l

219.44

18919

157893

(3006567) Chloride [Moles/time] in 24 hour Urine

2.08

0.89

1.0

—

(3006598) pH of Arterial cord blood

108

0.54

0.89

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

1.85

0.87

1.5

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

118

0.56

0.83

1.0

1.1

—

(4038314)

1.60

0.83

1.3

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.80

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.85

0.80

1.3

1.0

1.2

1.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

197

0.68

0.79

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

115

1.45

0.79

1.6

5.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.79

0.0

1.1

—

35.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

333

1.25

0.79

3.6

2.5

84.3

104.0

ng/l

0.61

148

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

0.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.78

0.0

1.1

—

66.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

432

0.79

0.76

2.7

2.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

250

2281

0.91

0.74

1.3

6.8

7.2

mmol/l

1.27

182

1590

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

390

1.22

0.73

1.4

1.3

27.0

38.9

1.50

247

(3007542) Rye IgE Ab [Units/volume] in Serum

1.54

0.72

1.0

1.1

0.2

0.6

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

135

1267

0.89

0.69

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

231

2105

0.91

0.69

1.5

1.3

3.4

3.8

ug/l

0.25

200

1871

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

179

1.30

0.63

1.6

1.2

22.1

20.7

mmol/l

0.67

151

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

606

1.16

0.62

1.8

1.9

—

(3029612) Listeria sp Ab [Titer] in Serum

1.67

0.61

1.2

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.59

0.61

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

108

1.39

0.60

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.44

0.60

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.39

0.52

1.5

1.4

413.3

310.8

umol/24h

0.48

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

446

1.16

0.51

1.0

1.1

18.4

8.3

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2354

19201

1.02

0.50

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

224

1.23

0.50

18.2

7.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20446

169753

1.01

0.48

4.6

4.2

1.4

1.5

mmol/l

152.40

18587

155696

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

671

1.12

0.46

1.9

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

138

1.27

0.43

1.7

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.54

0.42

1.0

1.4

1.8

2.0

mmol/24h

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

118

900

1.09

0.41

1.2

1.4

5.8

5.7

mmol/l

0.27

109

857

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5458

44979

1.01

0.41

1.7

1.6

1.5

1.3

mmol/l

18.23

4605

37662

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

314

0.85

0.37

2.1

1.8

1.7

3.2

ug/l

0.99

189

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.43

0.35

3.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

258

0.84

0.35

1.4

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

835

0.92

0.33

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

840

0.92

0.31

1.2

1.4

31.4

31.6

nmol/l

0.02

778

(3018001) Oat IgE Ab [Units/volume] in Serum

100

1.25

0.29

1.2

1.0

0.2

0.3

u/ml

—

(40768793) Breast Pathology biopsy report

467

3768

1.03

0.28

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.26

0.27

1.0

1.1

0.0

1.9

u/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

187

1.16

0.26

3.2

1.4

8.2

7.1

mmol/l

0.88

(40758358) Immune stain study

1.30

0.26

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

136

1199

0.94

0.25

2.0

1.4

1.0

0.9

g/l

0.90

136

1193

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.70

0.24

1.7

1.3

1.7

1.9

mg/l

—

(3022689) Creatine [Moles/volume] in Urine

482

0.92

0.23

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

182

1.14

0.22

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

264

1.10

0.19

6.1

6.9

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.22

0.18

1.0

1.1

9.3

8.2

mmol/l

1.40

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

149

1190

1.04

0.18

1.4

1.3

63.0

69.4

pmol/l

0.26

368

(3025130) Human papilloma virus identified in Specimen

276

2236

1.03

0.17

1.5

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

608

0.95

0.15

1.6

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

143

1.11

0.11

1.1

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.14

0.11

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

305

1.07

0.11

2.1

2.3

3.6

3.3

ug/l

0.28

(4146454)

234

1974

0.99

0.05

2.4

2.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

454

0.97

0.04

1.0

—

(4133840)

454

0.97

0.04

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

768

1.01

0.01

1.0

1.1

12.4

8.2

u/ml

0.53

117

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

808

1.00

0.00

2.0

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

135

1128

1.00

0.00

1.8

2.0

3.5

ug/l

0.03

116

1000

(3025577) Chromium [Mass/volume] in Blood

132

1099

1.00

0.00

1.9

2.1

2.2

ug/l

0.01

108

914

(3013762) Body weight Measured

0.99

0.00

1.2

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

1.6

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.3

—

18.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_MALAI_FATIG – Malaise and fatigue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malaise and fatigue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malaise and fatigue (R18_MALAI_FATIG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints